Hubbry Logo
EpigeneticsEpigeneticsMain
Open search
Epigenetics
Community hub
Epigenetics
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Epigenetics
Epigenetics
from Wikipedia

Epigenetic mechanisms

Epigenetics is the study of changes in gene expression that occur without altering the DNA sequence.[1] The Greek prefix epi- (ἐπι- "over, outside of, around") in epigenetics implies features that are "on top of" or "in addition to" the traditional DNA-sequence-based mechanism of inheritance.[2] Epigenetics usually involves changes that persist through cell division, and affect the regulation of gene expression.[3] Such effects on cellular and physiological traits may result from environmental factors, or be part of normal development.

The term also refers to the mechanism behind these changes: functionally relevant alterations to the genome that do not involve mutations in the nucleotide sequence. Examples of mechanisms that produce such changes are DNA methylation and histone modification, each of which alters how genes are expressed without altering the underlying DNA sequence.[4] Further, non-coding RNA sequences have been shown to play a key role in the regulation of gene expression.[5] Gene expression can be controlled through the action of repressor proteins that attach to silencer regions of the DNA. These epigenetic changes may last through cell divisions for the duration of the cell's life, and may also last for multiple generations, even though they do not involve changes in the underlying DNA sequence of the organism;[6] instead, non-genetic factors cause the organism's genes to behave (or "express themselves") differently.[7]

One example of an epigenetic change in eukaryotic biology is the process of cellular differentiation. During morphogenesis, totipotent stem cells become the various pluripotent cell lines of the embryo, which in turn become fully differentiated cells. In other words, as a single fertilized egg cell – the zygote – continues to divide, the resulting daughter cells develop into the different cell types in an organism, including neurons, muscle cells, epithelium, endothelium of blood vessels, etc., by activating some genes while inhibiting the expression of others.[8]

Definitions

[edit]

The term epigenesis has a generic meaning of "extra growth" that has been used in English since the 17th century.[9] In scientific publications, the term epigenetics started to appear in the 1930s (see Fig. on the right). However, its contemporary meaning emerged only in the 1990s.[10]

Number of patent families and non-patent documents with the term "epigenetic*" by publication year

A definition of the concept of epigenetic trait as a "stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence" was formulated at a Cold Spring Harbor meeting in 2008,[11] although alternate definitions that include non-heritable traits are still being used widely.[12]

Waddington's canalisation, 1940s

[edit]

The hypothesis of epigenetic changes affecting the expression of chromosomes was put forth by the Russian biologist Nikolai Koltsov.[13] From the generic meaning, and the associated adjective epigenetic, British embryologist C. H. Waddington coined the term epigenetics in 1942 as pertaining to epigenesis, in parallel to Valentin Haecker's 'phenogenetics' (Phänogenetik).[14] Epigenesis in the context of the biology of that period referred to the differentiation of cells from their initial totipotent state during embryonic development.[15]

When Waddington coined the term, the physical nature of genes and their role in heredity was not known. He used it instead as a conceptual model of how genetic components might interact with their surroundings to produce a phenotype; he used the phrase "epigenetic landscape" as a metaphor for biological development. Waddington held that cell fates were established during development in a process he called canalisation much as a marble rolls down to the point of lowest local elevation.[16] Waddington suggested visualising increasing irreversibility of cell type differentiation as ridges rising between the valleys where the marbles (analogous to cells) are travelling.[17]

In recent times, Waddington's notion of the epigenetic landscape has been rigorously formalized in the context of the systems dynamics state approach to the study of cell-fate.[18][19] Cell-fate determination is predicted to exhibit certain dynamics, such as attractor-convergence (the attractor can be an equilibrium point, limit cycle or strange attractor) or oscillatory.[19]

Contemporary

[edit]

In 1990, Robin Holliday defined epigenetics as "the study of the mechanisms of temporal and spatial control of gene activity during the development of complex organisms."[20]

More recent usage of the word in biology follows stricter definitions. As defined by Arthur Riggs and colleagues, it is "the study of mitotically and/or meiotically heritable changes in gene function that cannot be explained by changes in DNA sequence."[21]

The term has also been used, however, to describe processes which have not been demonstrated to be heritable, such as some forms of histone modification. Consequently, there are attempts to redefine "epigenetics" in broader terms that would avoid the constraints of requiring heritability. For example, Adrian Bird defined epigenetics as "the structural adaptation of chromosomal regions so as to register, signal or perpetuate altered activity states."[6] This definition would be inclusive of transient modifications associated with DNA repair or cell-cycle phases as well as stable changes maintained across multiple cell generations, but exclude others such as templating of membrane architecture and prions unless they impinge on chromosome function. Such redefinitions however are not universally accepted and are still subject to debate.[22] The NIH "Roadmap Epigenomics Project", which ran from 2008 to 2017, uses the following definition: "For purposes of this program, epigenetics refers to both heritable changes in gene activity and expression (in the progeny of cells or of individuals) and also stable, long-term alterations in the transcriptional potential of a cell that are not necessarily heritable."[23] In 2008, a consensus definition of the epigenetic trait, a "stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence," was made at a Cold Spring Harbor meeting.[11]

The similarity of the word to "genetics" has generated many parallel usages. The "epigenome" is a parallel to the word "genome", referring to the overall epigenetic state of a cell, and epigenomics refers to global analyses of epigenetic changes across the entire genome.[12] The phrase "genetic code" has also been adapted – the "epigenetic code" has been used to describe the set of epigenetic features that create different phenotypes in different cells from the same underlying DNA sequence. Taken to its extreme, the "epigenetic code" could represent the total state of the cell, with the position of each molecule accounted for in an epigenomic map, a diagrammatic representation of the gene expression, DNA methylation and histone modification status of a particular genomic region. More typically, the term is used in reference to systematic efforts to measure specific, relevant forms of epigenetic information such as the histone code or DNA methylation patterns.[citation needed]

Mechanisms

[edit]

Covalent modification of either DNA (e.g. cytosine methylation and hydroxymethylation) or of histone proteins (e.g. lysine acetylation, lysine and arginine methylation, serine and threonine phosphorylation, and lysine ubiquitination and sumoylation) play central roles in many types of epigenetic inheritance. Therefore, the word "epigenetics" is sometimes used as a synonym for these processes. However, this can be misleading. Chromatin remodeling is not always inherited, and not all epigenetic inheritance involves chromatin remodeling.[24] In 2019, a further lysine modification appeared in the scientific literature linking epigenetics modification to cell metabolism, i.e. lactylation.[25]

DNA associates with histone proteins to form chromatin.

Because the phenotype of a cell or individual is affected by which of its genes are transcribed, heritable transcription states can give rise to epigenetic effects. There are several layers of regulation of gene expression. One way that genes are regulated is through the remodeling of chromatin. Chromatin is the complex of DNA and the histone proteins with which it associates. If the way that DNA is wrapped around the histones changes, gene expression can change as well. Chromatin remodeling is accomplished through two main mechanisms:

  1. The first way is post translational modification of the amino acids that make up histone proteins. Histone proteins are made up of long chains of amino acids. If the amino acids that are in the chain are changed, the shape of the histone might be modified. DNA is not completely unwound during replication. It is possible, then, that the modified histones may be carried into each new copy of the DNA. Once there, these histones may act as templates, initiating the surrounding new histones to be shaped in the new manner. By altering the shape of the histones around them, these modified histones would ensure that a lineage-specific transcription program is maintained after cell division.
  2. The second way is the addition of methyl groups to the DNA, mostly at CpG sites, to convert cytosine to 5-methylcytosine. 5-Methylcytosine performs much like a regular cytosine, pairing with a guanine in double-stranded DNA. However, when methylated cytosines are present in CpG sites in the promoter and enhancer regions of genes, the genes are often repressed.[26][27] When methylated cytosines are present in CpG sites in the gene body (in the coding region excluding the transcription start site) expression of the gene is often enhanced. Transcription of a gene usually depends on a transcription factor binding to a (10 base or less) recognition sequence at the enhancer that interacts with the promoter region of that gene (Gene expression#Enhancers, transcription factors, mediator complex and DNA loops in mammalian transcription).[28] About 22% of transcription factors are inhibited from binding when the recognition sequence has a methylated cytosine. In addition, presence of methylated cytosines at a promoter region can attract methyl-CpG-binding domain (MBD) proteins. All MBDs interact with nucleosome remodeling and histone deacetylase complexes, which leads to gene silencing. In addition, another covalent modification involving methylated cytosine is its demethylation by TET enzymes. Hundreds of such demethylations occur, for instance, during learning and memory forming events in neurons.[29][30]

There is frequently a reciprocal relationship between DNA methylation and histone lysine methylation.[31] For instance, the methyl binding domain protein MBD1, attracted to and associating with methylated cytosine in a DNA CpG site, can also associate with H3K9 methyltransferase activity to methylate histone 3 at lysine 9. On the other hand, DNA maintenance methylation by DNMT1 appears to partly rely on recognition of histone methylation on the nucleosome present at the DNA site to carry out cytosine methylation on newly synthesized DNA.[31] There is further crosstalk between DNA methylation carried out by DNMT3A and DNMT3B and histone methylation so that there is a correlation between the genome-wide distribution of DNA methylation and histone methylation.[32]

Mechanisms of heritability of histone state are not well understood; however, much is known about the mechanism of heritability of DNA methylation state during cell division and differentiation. Heritability of methylation state depends on certain enzymes (such as DNMT1) that have a higher affinity for 5-methylcytosine than for cytosine. If this enzyme reaches a "hemimethylated" portion of DNA (where 5-methylcytosine is in only one of the two DNA strands) the enzyme will methylate the other half. However, it is now known that DNMT1 physically interacts with the protein UHRF1. UHRF1 has been recently recognized as essential for DNMT1-mediated maintenance of DNA methylation. UHRF1 is the protein that specifically recognizes hemi-methylated DNA, therefore bringing DNMT1 to its substrate to maintain DNA methylation.[32]

Activation
Repression
Some acetylations and some methylations of lysines (symbol K) are activation signals for transcription when present on a nucleosome, as shown in the top figure. Some methylations on lysines or arginine (R) are repression signals for transcription when present on a nucleosome, as shown in the bottom figure. Nucleosomes consist of four pairs of histone proteins in a tightly assembled core region plus up to 30% of each histone remaining in a loosely organized tail[33] (only one tail of each pair is shown). DNA is wrapped around the histone core proteins in chromatin. The lysines (K) are designated with a number showing their position as, for instance (K4), indicating lysine as the 4th amino acid from the amino (N) end of the tail in the histone protein. Methylations [Me], and acetylations [Ac] are common post-translational modifications on the lysines of the histone tails.

Although histone modifications occur throughout the entire sequence, the unstructured N-termini of histones (called histone tails) are particularly highly modified. These modifications include acetylation, methylation, ubiquitylation, phosphorylation, sumoylation, ribosylation and citrullination. Acetylation is the most highly studied of these modifications. For example, acetylation of the K14 and K9 lysines of the tail of histone H3 by histone acetyltransferase enzymes (HATs) is generally related to transcriptional competence[34] (see Figure).

One mode of thinking is that this tendency of acetylation to be associated with "active" transcription is biophysical in nature. Because it normally has a positively charged nitrogen at its end, lysine can bind the negatively charged phosphates of the DNA backbone. The acetylation event converts the positively charged amine group on the side chain into a neutral amide linkage. This removes the positive charge, thus loosening the DNA from the histone. When this occurs, complexes like SWI/SNF and other transcriptional factors can bind to the DNA and allow transcription to occur. This is the "cis" model of the epigenetic function. In other words, changes to the histone tails have a direct effect on the DNA itself.[35]

Another model of epigenetic function is the "trans" model. In this model, changes to the histone tails act indirectly on the DNA. For example, lysine acetylation may create a binding site for chromatin-modifying enzymes (or transcription machinery as well). This chromatin remodeler can then cause changes to the state of the chromatin. Indeed, a bromodomain – a protein domain that specifically binds acetyl-lysine – is found in many enzymes that help activate transcription, including the SWI/SNF complex. It may be that acetylation acts in this and the previous way to aid in transcriptional activation.

The idea that modifications act as docking modules for related factors is borne out by histone methylation as well. Methylation of lysine 9 of histone H3 has long been associated with constitutively transcriptionally silent chromatin (constitutive heterochromatin) (see bottom Figure). It has been determined that a chromodomain (a domain that specifically binds methyl-lysine) in the transcriptionally repressive protein HP1 recruits HP1 to K9 methylated regions. One example that seems to refute this biophysical model for methylation is that tri-methylation of histone H3 at lysine 4 is strongly associated with (and required for full) transcriptional activation (see top Figure). Tri-methylation, in this case, would introduce a fixed positive charge on the tail.

It has been shown that the histone lysine methyltransferase (KMT) is responsible for this methylation activity in the pattern of histones H3 & H4. This enzyme utilizes a catalytically active site called the SET domain (Suppressor of variegation, Enhancer of Zeste, Trithorax). The SET domain is a 130-amino acid sequence involved in modulating gene activities. This domain has been demonstrated to bind to the histone tail and causes the methylation of the histone.[36]

Differing histone modifications are likely to function in differing ways; acetylation at one position is likely to function differently from acetylation at another position. Also, multiple modifications may occur at the same time, and these modifications may work together to change the behavior of the nucleosome. The idea that multiple dynamic modifications regulate gene transcription in a systematic and reproducible way is called the histone code, although the idea that histone state can be read linearly as a digital information carrier has been largely debunked. One of the best-understood systems that orchestrate chromatin-based silencing is the SIR protein based silencing of the yeast hidden mating-type loci HML and HMR.

DNA methylation

[edit]

DNA methylation often occurs in repeated sequences, and helps to suppress the expression and movement of 'transposable elements':[37] Because 5-methylcytosine can spontaneously deaminate to thymidine(replacing nitrogen by oxygen), CpG sites are frequently mutated and have become rare in the genome, except at CpG islands where they typically remain unmethylated. Epigenetic changes of this type thus have the potential to direct increased frequencies of permanent genetic mutation. DNA methylation patterns are known to be established and modified in response to environmental factors by a complex interplay of at least three independent DNA methyltransferases, DNMT1, DNMT3A, and DNMT3B, the loss of any of which is lethal in mice.[38] DNMT1 is the most abundant methyltransferase in somatic cells,[39] localizes to replication foci,[40] has a 10–40-fold preference for hemimethylated DNA and interacts with the proliferating cell nuclear antigen (PCNA).[41]

By preferentially modifying hemimethylated DNA, DNMT1 transfers patterns of methylation to a newly synthesized strand after DNA replication, and therefore is often referred to as the 'maintenance' methyltransferase.[42] DNMT1 is essential for proper embryonic development, imprinting and X-inactivation.[38][43] To emphasize the difference of this molecular mechanism of inheritance from the canonical Watson-Crick base-pairing mechanism of transmission of genetic information, the term 'Epigenetic templating' was introduced.[44] Furthermore, in addition to the maintenance and transmission of methylated DNA states, the same principle could work in the maintenance and transmission of histone modifications and even cytoplasmic (structural) heritable states.[45]

RNA methylation

[edit]

RNA methylation of N6-methyladenosine (m6A) as the most abundant eukaryotic RNA modification has recently been recognized as an important gene regulatory mechanism.[46]

In 2011, it was demonstrated that the methylation of mRNA plays a critical role in human energy homeostasis. The obesity-associated FTO gene is shown to be able to demethylate N6-methyladenosine in RNA.[47][48]

Histone modifications

[edit]

Histones H3 and H4 can also be manipulated through demethylation using histone lysine demethylase (KDM). This recently identified enzyme has a catalytically active site called the Jumonji domain (JmjC). The demethylation occurs when JmjC utilizes multiple cofactors to hydroxylate the methyl group, thereby removing it. JmjC is capable of demethylating mono-, di-, and tri-methylated substrates.[49]

Chromosomal regions can adopt stable and heritable alternative states resulting in bistable gene expression without changes to the DNA sequence. Epigenetic control is often associated with alternative covalent modifications of histones.[50] The stability and heritability of states of larger chromosomal regions are suggested to involve positive feedback where modified nucleosomes recruit enzymes that similarly modify nearby nucleosomes.[51] A simplified stochastic model for this type of epigenetics is found here.[52][53]

It has been suggested that chromatin-based transcriptional regulation could be mediated by the effect of small RNAs. Small interfering RNAs can modulate transcriptional gene expression via epigenetic modulation of targeted promoters.[54]

RNA transcripts

[edit]

Sometimes, a gene, once activated, transcribes a product that directly or indirectly sustains its own activity. For example, Hnf4 and MyoD enhance the transcription of many liver-specific and muscle-specific genes, respectively, including their own, through the transcription factor activity of the proteins they encode. RNA signalling includes differential recruitment of a hierarchy of generic chromatin modifying complexes and DNA methyltransferases to specific loci by RNAs during differentiation and development.[55] Other epigenetic changes are mediated by the production of different splice forms of RNA, or by formation of double-stranded RNA (RNAi). Descendants of the cell in which the gene was turned on will inherit this activity, even if the original stimulus for gene-activation is no longer present. These genes are often turned on or off by signal transduction, although in some systems where syncytia or gap junctions are important, RNA may spread directly to other cells or nuclei by diffusion. A large amount of RNA and protein is contributed to the zygote by the mother during oogenesis or via nurse cells, resulting in maternal effect phenotypes. A smaller quantity of sperm RNA is transmitted from the father, but there is recent evidence that this epigenetic information can lead to visible changes in several generations of offspring.[56]

MicroRNAs

[edit]

MicroRNAs (miRNAs) are members of non-coding RNAs that range in size from 17 to 25 nucleotides. miRNAs regulate a large variety of biological functions in plants and animals.[57] So far, in 2013, about 2000 miRNAs have been discovered in humans and these can be found online in a miRNA database.[58] Each miRNA expressed in a cell may target about 100 to 200 messenger RNAs(mRNAs) that it downregulates.[59] Most of the downregulation of mRNAs occurs by causing the decay of the targeted mRNA, while some downregulation occurs at the level of translation into protein.[60]

It appears that about 60% of human protein coding genes are regulated by miRNAs.[61] Many miRNAs are epigenetically regulated. About 50% of miRNA genes are associated with CpG islands,[57] that may be repressed by epigenetic methylation. Transcription from methylated CpG islands is strongly and heritably repressed.[62] Other miRNAs are epigenetically regulated by either histone modifications or by combined DNA methylation and histone modification.[57]

sRNAs

[edit]

sRNAs are small (50–250 nucleotides), highly structured, non-coding RNA fragments found in bacteria. They control gene expression including virulence genes in pathogens and are viewed as new targets in the fight against drug-resistant bacteria.[63] They play an important role in many biological processes, binding to mRNA and protein targets in prokaryotes. Their phylogenetic analyses, for example through sRNA–mRNA target interactions or protein binding properties, are used to build comprehensive databases.[64] sRNA-gene maps based on their targets in microbial genomes are also constructed.[65]

Long non-coding RNAs

[edit]

Numerous investigations have demonstrated the pivotal involvement of long non-coding RNAs (lncRNAs) in the regulation of gene expression and chromosomal modifications, thereby exerting significant control over cellular differentiation. These long non-coding RNAs also contribute to genomic imprinting and the inactivation of the X chromosome.[66] In invertebrates such as social insects of honey bees, long non-coding RNAs are detected as a possible epigenetic mechanism via allele-specific genes underlying aggression via reciprocal crosses.[67]

Prions

[edit]

Prions are infectious forms of proteins. In general, proteins fold into discrete units that perform distinct cellular functions, but some proteins are also capable of forming an infectious conformational state known as a prion. Although often viewed in the context of infectious disease, prions are more loosely defined by their ability to catalytically convert other native state versions of the same protein to an infectious conformational state. It is in this latter sense that they can be viewed as epigenetic agents capable of inducing a phenotypic change without a modification of the genome.[68]

Fungal prions are considered by some to be epigenetic because the infectious phenotype caused by the prion can be inherited without modification of the genome. PSI+ and URE3, discovered in yeast in 1965 and 1971, are the two best studied of this type of prion.[69][70] Prions can have a phenotypic effect through the sequestration of protein in aggregates, thereby reducing that protein's activity. In PSI+ cells, the loss of the Sup35 protein (which is involved in termination of translation) causes ribosomes to have a higher rate of read-through of stop codons, an effect that results in suppression of nonsense mutations in other genes.[71] The ability of Sup35 to form prions may be a conserved trait. It could confer an adaptive advantage by giving cells the ability to switch into a PSI+ state and express dormant genetic features normally terminated by stop codon mutations.[72][73][74][75]

Prion-based epigenetics has also been observed in Saccharomyces cerevisiae.[76]

Molecular basis

[edit]

Epigenetic changes modify the activation of certain genes, but not the genetic code sequence of DNA.[77] The microstructure (not code) of DNA itself or the associated chromatin proteins may be modified, causing activation or silencing. This mechanism enables differentiated cells in a multicellular organism to express only the genes that are necessary for their own activity. Epigenetic changes are preserved when cells divide. Most epigenetic changes only occur within the course of one individual organism's lifetime; however, these epigenetic changes can be transmitted to the organism's offspring through a process called transgenerational epigenetic inheritance. Moreover, if gene inactivation occurs in a sperm or egg cell that results in fertilization, this epigenetic modification may also be transferred to the next generation.[78]

Specific epigenetic processes include paramutation, bookmarking, imprinting, gene silencing, X chromosome inactivation, position effect, DNA methylation reprogramming, transvection, maternal effects, the progress of carcinogenesis, many effects of teratogens, regulation of histone modifications and heterochromatin, and technical limitations affecting parthenogenesis and cloning.[79][80][81]

DNA damage

[edit]

DNA damage can also cause epigenetic changes.[82][83][84] DNA damage is very frequent, occurring on average about 60,000 times a day per cell of the human body (see DNA damage (naturally occurring)). These damages are largely repaired, however, epigenetic changes can still remain at the site of DNA repair.[85] In particular, a double strand break in DNA can initiate unprogrammed epigenetic gene silencing both by causing DNA methylation as well as by promoting silencing types of histone modifications (chromatin remodeling - see next section).[86] In addition, the enzyme Parp1 (poly(ADP)-ribose polymerase) and its product poly(ADP)-ribose (PAR) accumulate at sites of DNA damage as part of the repair process.[87] This accumulation, in turn, directs recruitment and activation of the chromatin remodeling protein, ALC1, that can cause nucleosome remodeling.[88] Nucleosome remodeling has been found to cause, for instance, epigenetic silencing of DNA repair gene MLH1.[21][89] DNA damaging chemicals, such as benzene, hydroquinone, styrene, carbon tetrachloride and trichloroethylene, cause considerable hypomethylation of DNA, some through the activation of oxidative stress pathways.[90]

Foods are known to alter the epigenetics of rats on different diets.[91] Some food components epigenetically increase the levels of DNA repair enzymes such as MGMT and MLH1[92] and p53.[93] Other food components can reduce DNA damage, such as soy isoflavones. In one study, markers for oxidative stress, such as modified nucleotides that can result from DNA damage, were decreased by a 3-week diet supplemented with soy.[94] A decrease in oxidative DNA damage was also observed 2 h after consumption of anthocyanin-rich bilberry (Vaccinium myrtillius L.) pomace extract.[95]

DNA repair

[edit]

Damage to DNA is very common and is constantly being repaired. Epigenetic alterations can accompany DNA repair of oxidative damage or double-strand breaks. In human cells, oxidative DNA damage occurs about 10,000 times a day and DNA double-strand breaks occur about 10 to 50 times a cell cycle in somatic replicating cells (see DNA damage (naturally occurring)). The selective advantage of DNA repair is to allow the cell to survive in the face of DNA damage. The selective advantage of epigenetic alterations that occur with DNA repair is not clear.[citation needed]

Repair of oxidative DNA damage can alter epigenetic markers

[edit]

In the steady state (with endogenous damages occurring and being repaired), there are about 2,400 oxidatively damaged guanines that form 8-oxo-2'-deoxyguanosine (8-OHdG) in the average mammalian cell DNA.[96] 8-OHdG constitutes about 5% of the oxidative damages commonly present in DNA.[97] The oxidized guanines do not occur randomly among all guanines in DNA. There is a sequence preference for the guanine at a methylated CpG site (a cytosine followed by guanine along its 5' → 3' direction and where the cytosine is methylated (5-mCpG)).[98] A 5-mCpG site has the lowest ionization potential for guanine oxidation.[citation needed]

Initiation of DNA demethylation at a CpG site. In adult somatic cells DNA methylation typically occurs in the context of CpG dinucleotides (CpG sites), forming 5-methylcytosine-pG, or 5mCpG. Reactive oxygen species (ROS) may attack guanine at the dinucleotide site, forming 8-hydroxy-2'-deoxyguanosine (8-OHdG), and resulting in a 5mCp-8-OHdG dinucleotide site. The base excision repair enzyme OGG1 targets 8-OHdG and binds to the lesion without immediate excision. OGG1, present at a 5mCp-8-OHdG site recruits TET1 and TET1 oxidizes the 5mC adjacent to the 8-OHdG. This initiates demethylation of 5mC.[99]

Oxidized guanine has mispairing potential and is mutagenic.[100] Oxoguanine glycosylase (OGG1) is the primary enzyme responsible for the excision of the oxidized guanine during DNA repair. OGG1 finds and binds to an 8-OHdG within a few seconds.[101] However, OGG1 does not immediately excise 8-OHdG. In HeLa cells half maximum removal of 8-OHdG occurs in 30 minutes,[102] and in irradiated mice, the 8-OHdGs induced in the mouse liver are removed with a half-life of 11 minutes.[97]

When OGG1 is present at an oxidized guanine within a methylated CpG site it recruits TET1 to the 8-OHdG lesion (see Figure). This allows TET1 to demethylate an adjacent methylated cytosine. Demethylation of cytosine is an epigenetic alteration.[citation needed]

As an example, when human mammary epithelial cells were treated with H2O2 for six hours, 8-OHdG increased about 3.5-fold in DNA and this caused about 80% demethylation of the 5-methylcytosines in the genome.[99] Demethylation of CpGs in a gene promoter by TET enzyme activity increases transcription of the gene into messenger RNA.[103] In cells treated with H2O2, one particular gene was examined, BACE1.[99] The methylation level of the BACE1 CpG island was reduced (an epigenetic alteration) and this allowed about 6.5 fold increase of expression of BACE1 messenger RNA.[citation needed]

While six-hour incubation with H2O2 causes considerable demethylation of 5-mCpG sites, shorter times of H2O2 incubation appear to promote other epigenetic alterations. Treatment of cells with H2O2 for 30 minutes causes the mismatch repair protein heterodimer MSH2-MSH6 to recruit DNA methyltransferase 1 (DNMT1) to sites of some kinds of oxidative DNA damage.[104] This could cause increased methylation of cytosines (epigenetic alterations) at these locations.

Jiang et al.[105] treated HEK 293 cells with agents causing oxidative DNA damage, (potassium bromate (KBrO3) or potassium chromate (K2CrO4)). Base excision repair (BER) of oxidative damage occurred with the DNA repair enzyme polymerase beta localizing to oxidized guanines. Polymerase beta is the main human polymerase in short-patch BER of oxidative DNA damage. Jiang et al.[105] also found that polymerase beta recruited the DNA methyltransferase protein DNMT3b to BER repair sites. They then evaluated the methylation pattern at the single nucleotide level in a small region of DNA including the promoter region and the early transcription region of the BRCA1 gene. Oxidative DNA damage from bromate modulated the DNA methylation pattern (caused epigenetic alterations) at CpG sites within the region of DNA studied. In untreated cells, CpGs located at −189, −134, −29, −19, +16, and +19 of the BRCA1 gene had methylated cytosines (where numbering is from the messenger RNA transcription start site, and negative numbers indicate nucleotides in the upstream promoter region). Bromate treatment-induced oxidation resulted in the loss of cytosine methylation at −189, −134, +16 and +19 while also leading to the formation of new methylation at the CpGs located at −80, −55, −21 and +8 after DNA repair was allowed.

Homologous recombinational repair alters epigenetic markers

[edit]

At least four articles report the recruitment of DNA methyltransferase 1 (DNMT1) to sites of DNA double-strand breaks.[106][85][107][108] During homologous recombinational repair (HR) of the double-strand break, the involvement of DNMT1 causes the two repaired strands of DNA to have different levels of methylated cytosines. One strand becomes frequently methylated at about 21 CpG sites downstream of the repaired double-strand break. The other DNA strand loses methylation at about six CpG sites that were previously methylated downstream of the double-strand break, as well as losing methylation at about five CpG sites that were previously methylated upstream of the double-strand break. When the chromosome is replicated, this gives rise to one daughter chromosome that is heavily methylated downstream of the previous break site and one that is unmethylated in the region both upstream and downstream of the previous break site. With respect to the gene that was broken by the double-strand break, half of the progeny cells express that gene at a high level and in the other half of the progeny cells expression of that gene is repressed. When clones of these cells were maintained for three years, the new methylation patterns were maintained over that time period.[109]

In mice with a CRISPR-mediated homology-directed recombination insertion in their genome there were a large number of increased methylations of CpG sites within the double-strand break-associated insertion.[110]

Non-homologous end joining can cause some epigenetic marker alterations

[edit]

Non-homologous end joining (NHEJ) repair of a double-strand break can cause a small number of demethylations of pre-existing cytosine DNA methylations downstream of the repaired double-strand break.[85] Further work by Allen et al.[111] showed that NHEJ of a DNA double-strand break in a cell could give rise to some progeny cells having repressed expression of the gene harboring the initial double-strand break and some progeny having high expression of that gene due to epigenetic alterations associated with NHEJ repair. The frequency of epigenetic alterations causing repression of a gene after an NHEJ repair of a DNA double-strand break in that gene may be about 0.9%.[107]

Techniques used to study epigenetics

[edit]

Epigenetic research uses a wide range of molecular biological techniques to further understanding of epigenetic phenomena. These techniques include chromatin immunoprecipitation (together with its large-scale variants ChIP-on-chip and ChIP-Seq), fluorescent in situ hybridization, methylation-sensitive restriction enzymes, DNA adenine methyltransferase identification (DamID) and bisulfite sequencing.[112] Furthermore, the use of bioinformatics methods has a role in computational epigenetics.[112]

Chromatin Immunoprecipitation

[edit]

Chromatin Immunoprecipitation (ChIP) has helped bridge the gap between DNA and epigenetic interactions.[113] With the use of ChIP, researchers are able to make findings in regards to gene regulation, transcription mechanisms, and chromatin structure.[113]

Fluorescent in situ hybridization

[edit]

Fluorescent in situ hybridization (FISH) is very important to understand epigenetic mechanisms.[114] FISH can be used to find the location of genes on chromosomes, as well as finding noncoding RNAs.[114][115] FISH is predominantly used for detecting chromosomal abnormalities in humans.[115]

Methylation-sensitive restriction enzymes

[edit]

Methylation sensitive restriction enzymes paired with PCR is a way to evaluate methylation in DNA - specifically the CpG sites.[116] If DNA is methylated, the restriction enzymes will not cleave the strand.[116] Contrarily, if the DNA is not methylated, the enzymes will cleave the strand and it will be amplified by PCR.[116]

Bisulfite sequencing

[edit]

Bisulfite sequencing is another way to evaluate DNA methylation. Cytosine will be changed to uracil from being treated with sodium bisulfite, whereas methylated cytosines will not be affected.[116][117][118]

Nanopore sequencing

[edit]

Certain sequencing methods, such as nanopore sequencing, allow sequencing of native DNA. Native (=unamplified) DNA retains the epigenetic modifications which would otherwise be lost during the amplification step. Nanopore basecaller models can distinguish between the signals obtained for epigenetically modified bases and unaltered based and provide an epigenetic profile in addition to the sequencing result.[119]

Structural inheritance

[edit]

In ciliates such as Tetrahymena and Paramecium, genetically identical cells show heritable differences in the patterns of ciliary rows on their cell surface. Experimentally altered patterns can be transmitted to daughter cells. It seems existing structures act as templates for new structures. The mechanisms of such inheritance are unclear, but reasons exist to assume that multicellular organisms also use existing cell structures to assemble new ones.[120][121][122]

Nucleosome positioning

[edit]

Eukaryotic genomes have numerous nucleosomes. Nucleosome position is not random, and determine the accessibility of DNA to regulatory proteins. Promoters active in different tissues have been shown to have different nucleosome positioning features.[123] This determines differences in gene expression and cell differentiation. It has been shown that at least some nucleosomes are retained in sperm cells (where most but not all histones are replaced by protamines). Thus nucleosome positioning is to some degree inheritable. Recent studies have uncovered connections between nucleosome positioning and other epigenetic factors, such as DNA methylation and hydroxymethylation.[124]

Histone variants

[edit]

Different histone variants are incorporated into specific regions of the genome non-randomly. Their differential biochemical characteristics can affect genome functions via their roles in gene regulation,[125] and maintenance of chromosome structures.[126]

Genomic architecture

[edit]

The three-dimensional configuration of the genome (the 3D genome) is complex, dynamic and crucial for regulating genomic function and nuclear processes such as DNA replication, transcription and DNA-damage repair.[127]

Functions and consequences

[edit]

In the brain

[edit]

Memory

[edit]

Memory formation and maintenance are due to epigenetic alterations that cause the required dynamic changes in gene transcription that create and renew memory in neurons.[30]

An event can set off a chain of reactions that result in altered methylations of a large set of genes in neurons, which give a representation of the event, a memory.[30]

Including medial prefrontal cortex (mPFC)

Areas of the brain important in the formation of memories include the hippocampus, medial prefrontal cortex (mPFC), anterior cingulate cortex and amygdala, as shown in the diagram of the human brain in this section.[128]

When a strong memory is created, as in a rat subjected to contextual fear conditioning (CFC), one of the earliest events to occur is that more than 100 DNA double-strand breaks are formed by topoisomerase IIB in neurons of the hippocampus and the medial prefrontal cortex (mPFC).[129] These double-strand breaks are at specific locations that allow activation of transcription of immediate early genes (IEGs) that are important in memory formation, allowing their expression in mRNA, with peak mRNA transcription at seven to ten minutes after CFC.[129][130]

Two important IEGs in memory formation are EGR1[131] and the alternative promoter variant of DNMT3A, DNMT3A2.[132] EGR1 protein binds to DNA at its binding motifs, 5′-GCGTGGGCG-3′ or 5′-GCGGGGGCGG-3', and there are about 12,000 genome locations at which EGR1 protein can bind.[133] EGR1 protein binds to DNA in gene promoter and enhancer regions. EGR1 recruits the demethylating enzyme TET1 to an association, and brings TET1 to about 600 locations on the genome where TET1 can then demethylate and activate the associated genes.[133]

Cytosine and 5-methylcytosine

The DNA methyltransferases DNMT3A1, DNMT3A2 and DNMT3B can all methylate cytosines (see image this section) at CpG sites in or near the promoters of genes. As shown by Manzo et al.,[134] these three DNA methyltransferases differ in their genomic binding locations and DNA methylation activity at different regulatory sites. Manzo et al. located 3,970 genome regions exclusively enriched for DNMT3A1, 3,838 regions for DNMT3A2 and 3,432 regions for DNMT3B. When DNMT3A2 is newly induced as an IEG (when neurons are activated), many new cytosine methylations occur, presumably in the target regions of DNMT3A2. Oliviera et al.[132] found that the neuronal activity-inducible IEG levels of Dnmt3a2 in the hippocampus determined the ability to form long-term memories.

Rats form long-term associative memories after contextual fear conditioning (CFC).[135] Duke et al.[29] found that 24 hours after CFC in rats, in hippocampus neurons, 2,097 genes (9.17% of the genes in the rat genome) had altered methylation. When newly methylated cytosines are present in CpG sites in the promoter regions of genes, the genes are often repressed, and when newly demethylated cytosines are present the genes may be activated.[136] After CFC, there were 1,048 genes with reduced mRNA expression and 564 genes with upregulated mRNA expression. Similarly, when mice undergo CFC, one hour later in the hippocampus region of the mouse brain there are 675 demethylated genes and 613 hypermethylated genes.[137] However, memories do not remain in the hippocampus, but after four or five weeks the memories are stored in the anterior cingulate cortex.[138] In the studies on mice after CFC, Halder et al.[137] showed that four weeks after CFC there were at least 1,000 differentially methylated genes and more than 1,000 differentially expressed genes in the anterior cingulate cortex, while at the same time the altered methylations in the hippocampus were reversed.

The epigenetic alteration of methylation after a new memory is established creates a different pool of nuclear mRNAs. As reviewed by Bernstein,[30] the epigenetically determined new mix of nuclear mRNAs are often packaged into neuronal granules, or messenger RNP, consisting of mRNA, small and large ribosomal subunits, translation initiation factors and RNA-binding proteins that regulate mRNA function. These neuronal granules are transported from the neuron nucleus and are directed, according to 3′ untranslated regions of the mRNA in the granules (their "zip codes"), to neuronal dendrites. Roughly 2,500 mRNAs may be localized to the dendrites of hippocampal pyramidal neurons and perhaps 450 transcripts are in excitatory presynaptic nerve terminals (dendritic spines). The altered assortments of transcripts (dependent on epigenetic alterations in the neuron nucleus) have different sensitivities in response to signals, which is the basis of altered synaptic plasticity. Altered synaptic plasticity is often considered the neurochemical foundation of learning and memory.

Aging

[edit]

Epigenetics play a major role in brain aging and age-related cognitive decline, with relevance to life extension.[139][140][141][142][143]

Other and general

[edit]

In adulthood, changes in the epigenome are important for various higher cognitive functions. Dysregulation of epigenetic mechanisms is implicated in neurodegenerative disorders and diseases. Epigenetic modifications in neurons are dynamic and reversible.[144] Epigenetic regulation impacts neuronal action, affecting learning, memory, and other cognitive processes.[145]

Early events, including during embryonic development, can influence development, cognition, and health outcomes through epigenetic mechanisms.[146]

Epigenetic mechanisms have been proposed as "a potential molecular mechanism for effects of endogenous hormones on the organization of developing brain circuits".[147]

Nutrients could interact with the epigenome to "protect or boost cognitive processes across the lifespan".[148][149]

A review suggests neurobiological effects of physical exercise via epigenetics seem "central to building an 'epigenetic memory' to influence long-term brain function and behavior" and may even be heritable.[150]

With the axo-ciliary synapse, there is communication between serotonergic axons and antenna-like primary cilia of CA1 pyramidal neurons that alters the neuron's epigenetic state in the nucleus via the signalling distinct from that at the plasma membrane (and longer-term).[151][152]

Epigenetics also play a major role in the brain evolution in and to humans.[153]

Development

[edit]

Developmental epigenetics can be divided into predetermined and probabilistic epigenesis. Predetermined epigenesis is a unidirectional movement from structural development in DNA to the functional maturation of the protein. "Predetermined" here means that development is scripted and predictable. Probabilistic epigenesis on the other hand is a bidirectional structure-function development with experiences and external molding development.[154]

Somatic epigenetic inheritance, particularly through DNA and histone covalent modifications and nucleosome repositioning, is very important in the development of multicellular eukaryotic organisms.[124] The genome sequence is static (with some notable exceptions), but cells differentiate into many different types, which perform different functions, and respond differently to the environment and intercellular signaling. Thus, as individuals develop, morphogens activate or silence genes in an epigenetically heritable fashion, giving cells a memory. In mammals, most cells terminally differentiate, with only stem cells retaining the ability to differentiate into several cell types ("totipotency" and "multipotency"). In mammals, some stem cells continue producing newly differentiated cells throughout life, such as in neurogenesis, but mammals are not able to respond to loss of some tissues, for example, the inability to regenerate limbs, which some other animals are capable of. Epigenetic modifications regulate the transition from neural stem cells to glial progenitor cells (for example, differentiation into oligodendrocytes is regulated by the deacetylation and methylation of histones).[155] Unlike animals, plant cells do not terminally differentiate, remaining totipotent with the ability to give rise to a new individual plant. While plants do utilize many of the same epigenetic mechanisms as animals, such as chromatin remodeling, it has been hypothesized that some kinds of plant cells do not use or require "cellular memories", resetting their gene expression patterns using positional information from the environment and surrounding cells to determine their fate.[156]

Epigenetic changes can occur in response to environmental exposure – for example, maternal dietary supplementation with genistein (250 mg/kg) have epigenetic changes affecting expression of the agouti gene, which affects their fur color, weight, and propensity to develop cancer.[157][158][159] Ongoing research is focused on exploring the impact of other known teratogens, such as diabetic embryopathy, on methylation signatures.[160]

Controversial results from one study suggested that traumatic experiences might produce an epigenetic signal that is capable of being passed to future generations. Mice were trained, using foot shocks, to fear a cherry blossom odor. The investigators reported that the mouse offspring had an increased aversion to this specific odor.[161][162] They suggested epigenetic changes that increase gene expression, rather than in DNA itself, in a gene, M71, that governs the functioning of an odor receptor in the nose that responds specifically to this cherry blossom smell. There were physical changes that correlated with olfactory (smell) function in the brains of the trained mice and their descendants. Several criticisms were reported, including the study's low statistical power as evidence of some irregularity such as bias in reporting results.[163] Due to limits of sample size, there is a probability that an effect will not be demonstrated to within statistical significance even if it exists. The criticism suggested that the probability that all the experiments reported would show positive results if an identical protocol was followed, assuming the claimed effects exist, is merely 0.4%. The authors also did not indicate which mice were siblings, and treated all of the mice as statistically independent.[164] The original researchers pointed out negative results in the paper's appendix that the criticism omitted in its calculations, and undertook to track which mice were siblings in the future.[165]

Transgenerational

[edit]

Epigenetic mechanisms were a necessary part of the evolutionary origin of cell differentiation.[166][need quotation to verify] Although epigenetics in multicellular organisms is generally thought to be a mechanism involved in differentiation, with epigenetic patterns "reset" when organisms reproduce, there have been some observations of transgenerational epigenetic inheritance (e.g., the phenomenon of paramutation observed in maize). Although most of these multigenerational epigenetic traits are gradually lost over several generations, the possibility remains that multigenerational epigenetics could be another aspect to evolution and adaptation. As mentioned above, some define epigenetics as heritable.

A sequestered germ line or Weismann barrier is specific to animals, and epigenetic inheritance is more common in plants and microbes. Eva Jablonka, Marion J. Lamb and Étienne Danchin have argued that these effects may require enhancements to the standard conceptual framework of the modern synthesis and have called for an extended evolutionary synthesis.[167][168][169] Other evolutionary biologists, such as John Maynard Smith, have incorporated epigenetic inheritance into population-genetics models[170] or are openly skeptical of the extended evolutionary synthesis (Michael Lynch).[171] Thomas Dickins and Qazi Rahman state that epigenetic mechanisms such as DNA methylation and histone modification are genetically inherited under the control of natural selection and therefore fit under the earlier "modern synthesis".[172]

Two important ways in which epigenetic inheritance can differ from traditional genetic inheritance, with important consequences for evolution, are:

  • rates of epimutation can be much faster than rates of mutation[173]
  • the epimutations are more easily reversible[174]

In plants, heritable DNA methylation mutations are 100,000 times more likely to occur compared to DNA mutations.[175] An epigenetically inherited element such as the PSI+ system can act as a "stop-gap", good enough for short-term adaptation that allows the lineage to survive for long enough for mutation and/or recombination to genetically assimilate the adaptive phenotypic change.[176] The existence of this possibility increases the evolvability of a species.

More than 100 cases of transgenerational epigenetic inheritance phenomena have been reported in a wide range of organisms, including prokaryotes, plants, and animals.[177] For instance, mourning-cloak butterflies will change color through hormone changes in response to experimentation of varying temperatures.[178]

The filamentous fungus Neurospora crassa is a prominent model system for understanding the control and function of cytosine methylation. In this organism, DNA methylation is associated with relics of a genome-defense system called RIP (repeat-induced point mutation) and silences gene expression by inhibiting transcription elongation.[179]

The yeast prion PSI is generated by a conformational change of a translation termination factor, which is then inherited by daughter cells. This can provide a survival advantage under adverse conditions, exemplifying epigenetic regulation which enables unicellular organisms to respond rapidly to environmental stress. Prions can be viewed as epigenetic agents capable of inducing a phenotypic change without modification of the genome.[180]

Direct detection of epigenetic marks in microorganisms is possible with single molecule real time sequencing, in which polymerase sensitivity allows for measuring methylation and other modifications as a DNA molecule is being sequenced.[181] Several projects have demonstrated the ability to collect genome-wide epigenetic data in bacteria.[182][183][184][185]

Epigenetics in bacteria

[edit]
Escherichia coli bacteria

While epigenetics is of fundamental importance in eukaryotes, especially metazoans, it plays a different role in bacteria.[186] Most importantly, eukaryotes use epigenetic mechanisms primarily to regulate gene expression which bacteria rarely do. However, bacteria make widespread use of postreplicative DNA methylation for the epigenetic control of DNA-protein interactions. Bacteria also use DNA adenine methylation (rather than DNA cytosine methylation) as an epigenetic signal. DNA adenine methylation is important in bacteria virulence in organisms such as Escherichia coli, Salmonella, Vibrio, Yersinia, Haemophilus, and Brucella. In Alphaproteobacteria, methylation of adenine regulates the cell cycle and couples gene transcription to DNA replication. In Gammaproteobacteria, adenine methylation provides signals for DNA replication, chromosome segregation, mismatch repair, packaging of bacteriophage, transposase activity and regulation of gene expression.[180][187] There exists a genetic switch controlling Streptococcus pneumoniae (the pneumococcus) that allows the bacterium to randomly change its characteristics into six alternative states that could pave the way to improved vaccines. Each form is randomly generated by a phase variable methylation system. The ability of the pneumococcus to cause deadly infections is different in each of these six states. Similar systems exist in other bacterial genera.[188] In Bacillota such as Clostridioides difficile, adenine methylation regulates sporulation, biofilm formation and host-adaptation.[189]

Medicine

[edit]

Epigenetics has many and varied potential medical applications.[190]

Twins

[edit]

Direct comparisons of identical twins constitute an optimal model for interrogating environmental epigenetics. In the case of humans with different environmental exposures, monozygotic (identical) twins were epigenetically indistinguishable during their early years, while older twins had remarkable differences in the overall content and genomic distribution of 5-methylcytosine DNA and histone acetylation.[10] The twin pairs who had spent less of their lifetime together and/or had greater differences in their medical histories were those who showed the largest differences in their levels of 5-methylcytosine DNA and acetylation of histones H3 and H4.[191]

Dizygotic (fraternal) and monozygotic (identical) twins show evidence of epigenetic influence in humans.[191][192][193] DNA sequence differences that would be abundant in a singleton-based study do not interfere with the analysis. Environmental differences can produce long-term epigenetic effects, and different developmental monozygotic twin subtypes may be different with respect to their susceptibility to be discordant from an epigenetic point of view.[194]

A high-throughput study, which denotes technology that looks at extensive genetic markers, focused on epigenetic differences between monozygotic twins to compare global and locus-specific changes in DNA methylation and histone modifications in a sample of 40 monozygotic twin pairs.[191] In this case, only healthy twin pairs were studied, but a wide range of ages was represented, between 3 and 74 years. One of the major conclusions from this study was that there is an age-dependent accumulation of epigenetic differences between the two siblings of twin pairs. This accumulation suggests the existence of epigenetic "drift". Epigenetic drift is the term given to epigenetic modifications as they occur as a direct function with age. While age is a known risk factor for many diseases, age-related methylation has been found to occur differentially at specific sites along the genome. Over time, this can result in measurable differences between biological and chronological age. Epigenetic changes have been found to be reflective of lifestyle and may act as functional biomarkers of disease before clinical threshold is reached.[195]

A more recent study, where 114 monozygotic twins and 80 dizygotic twins were analyzed for the DNA methylation status of around 6000 unique genomic regions, concluded that epigenetic similarity at the time of blastocyst splitting may also contribute to phenotypic similarities in monozygotic co-twins. This supports the notion that microenvironment at early stages of embryonic development can be quite important for the establishment of epigenetic marks.[192] Congenital genetic disease is well understood and it is clear that epigenetics can play a role, for example, in the case of Angelman syndrome and Prader–Willi syndrome. These are normal genetic diseases caused by gene deletions or inactivation of the genes but are unusually common because individuals are essentially hemizygous because of genomic imprinting, and therefore a single gene knock out is sufficient to cause the disease, where most cases would require both copies to be knocked out.[196]

Genomic imprinting

[edit]

Some human disorders are associated with genomic imprinting, a phenomenon in mammals where the father and mother contribute different epigenetic patterns for specific genomic loci in their germ cells.[197] The best-known case of imprinting in human disorders is that of Angelman syndrome and Prader–Willi syndrome – both can be produced by the same genetic mutation, chromosome 15q partial deletion, and the particular syndrome that will develop depends on whether the mutation is inherited from the child's mother or from their father.[198]

In the Överkalix study, paternal (but not maternal) grandsons[199] of Swedish men who were exposed during preadolescence to famine in the 19th century were less likely to die of cardiovascular disease. If food was plentiful, then diabetes mortality in the grandchildren increased, suggesting that this was a transgenerational epigenetic inheritance.[200] The opposite effect was observed for females – the paternal (but not maternal) granddaughters of women who experienced famine while in the womb (and therefore while their eggs were being formed) lived shorter lives on average.[201]

Examples of drugs altering gene expression from epigenetic events

[edit]

The use of beta-lactam antibiotics can alter glutamate receptor activity and the action of cyclosporine on multiple transcription factors. Additionally, lithium can impact autophagy of aberrant proteins, and opioid drugs via chronic use can increase the expression of genes associated with addictive phenotypes.[202]

Parental nutrition, in utero exposure to stress or endocrine disrupting chemicals,[203] male-induced maternal effects such as the attraction of differential mate quality, and maternal as well as paternal age, and offspring gender could all possibly influence whether a germline epimutation is ultimately expressed in offspring and the degree to which intergenerational inheritance remains stable throughout posterity.[204] However, whether and to what extent epigenetic effects can be transmitted across generations remains unclear, particularly in humans.[205][206]

Addiction

[edit]

Addiction is a disorder of the brain's reward system which arises through transcriptional and neuroepigenetic mechanisms and occurs over time from chronically high levels of exposure to an addictive stimulus (e.g., morphine, cocaine, sexual intercourse, gambling).[207][208][209] Transgenerational epigenetic inheritance of addictive phenotypes has been noted to occur in preclinical studies.[210][211] However, robust evidence in support of the persistence of epigenetic effects across multiple generations has yet to be established in humans; for example, an epigenetic effect of prenatal exposure to smoking that is observed in great-grandchildren who had not been exposed.[205]

Research

[edit]

The two forms of heritable information, namely genetic and epigenetic, are collectively called dual inheritance. Members of the APOBEC/AID family of cytosine deaminases may concurrently influence genetic and epigenetic inheritance using similar molecular mechanisms, and may be a point of crosstalk between these conceptually compartmentalized processes.[212]

Fluoroquinolone antibiotics induce epigenetic changes in mammalian cells through iron chelation. This leads to epigenetic effects through inhibition of α-ketoglutarate-dependent dioxygenases that require iron as a co-factor.[213]

Various pharmacological agents are applied for the production of induced pluripotent stem cells (iPSC) or maintain the embryonic stem cell (ESC) phenotypic via epigenetic approach. Adult stem cells like bone marrow stem cells have also shown a potential to differentiate into cardiac competent cells when treated with G9a histone methyltransferase inhibitor BIX01294.[214][215]

Cell plasticity, which is the adaptation of cells to stimuli without changes in their genetic code, requires epigenetic changes. These have been observed in cell plasticity in cancer cells during epithelial-to-mesenchymal transition[216] and also in immune cells, such as macrophages.[217] Interestingly, metabolic changes underlie these adaptations, since various metabolites play crucial roles in the chemistry of epigenetic marks. This includes for instance alpha-ketoglutarate, which is required for histone demethylation, and acetyl-Coenzyme A, which is required for histone acetylation.

Epigenome editing

[edit]

Epigenetic regulation of gene expression that could be altered or used in epigenome editing are or include mRNA/lncRNA modification, DNA methylation modification and histone modification.[218][219][220]

CpG sites, SNPs and biological traits

[edit]

Methylation is a widely characterized mechanism of genetic regulation that can determine biological traits. However, strong experimental evidences correlate methylation patterns in SNPs as an important additional feature for the classical activation/inhibition epigenetic dogma. Molecular interaction data, supported by colocalization analyses, identify multiple nuclear regulatory pathways, linking sequence variation to disturbances in DNA methylation and molecular and phenotypic variation.[221]

UBASH3B locus

[edit]

UBASH3B encodes a protein with tyrosine phosphatase activity, which has been previously linked to advanced neoplasia.[222] SNP rs7115089 was identified as influencing DNA methylation and expression of this locus, as well as and Body Mass Index (BMI).[221] In fact, SNP rs7115089 is strongly associated with BMI[223] and with genetic variants linked to other cardiovascular and metabolic traits in GWASs.[224][225][226] New studies suggesting UBASH3B as a potential mediator of adiposity and cardiometabolic disease.[221] In addition, animal models demonstrated that UBASH3B expression is an indicator of caloric restriction that may drive programmed susceptibility to obesity and it is associated with other measures of adiposity in human peripherical blood.[227]

NFKBIE locus

[edit]

SNP rs730775 is located in the first intron of NFKBIE and is a cis eQTL for NFKBIE in whole blood.[221] Nuclear factor (NF)-κB inhibitor ε (NFKBIE) directly inhibits NF-κB1 activity and is significantly co-expressed with NF-κB1, also, it is associated with rheumatoid arthritis.[228] Colocalization analysis supports that variants for the majority of the CpG sites in SNP rs730775 cause genetic variation at the NFKBIE locus which is suggestible linked to rheumatoid arthritis through trans acting regulation of DNA methylation by NF-κB.[221]

FADS1 locus

[edit]

Fatty acid desaturase 1 (FADS1) is a key enzyme in the metabolism of fatty acids.[229] Moreover, rs174548 in the FADS1 gene shows increased correlation with DNA methylation in people with high abundance of CD8+ T cells.[221] SNP rs174548 is strongly associated with concentrations of arachidonic acid and other metabolites in fatty acid metabolism,[230][231] blood eosinophil counts.[232] and inflammatory diseases such as asthma.[233] Interaction results indicated a correlation between rs174548 and asthma, providing new insights about fatty acid metabolism in CD8+ T cells with immune phenotypes.[221]

Pseudoscience

[edit]

As epigenetics is in the early stages of development as a science and is surrounded by sensationalism in the public media, David Gorski and geneticist Adam Rutherford have advised caution against the proliferation of false and pseudoscientific conclusions by new age authors making unfounded suggestions that a person's genes and health can be manipulated by mind control. Misuse of the scientific term by quack authors has produced misinformation among the general public.[2][234]

See also

[edit]

References

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Epigenetics is the study of heritable changes in gene expression that occur without alterations to the underlying DNA sequence, allowing cells to control which genes are active or silenced in response to developmental cues, environmental influences, and other factors. These modifications, collectively known as the epigenome, regulate gene activity by adding or removing chemical tags to DNA or associated proteins, ensuring that different cell types—such as neurons and liver cells—express distinct sets of genes from the same genome despite identical DNA. Coined in the 1940s by Conrad Waddington to describe the interaction between genes and their products during development, the term has evolved to encompass mechanisms that are mitotically heritable during cell division and potentially meiotically heritable across generations. The primary mechanisms of epigenetics include DNA methylation and histone modifications, which together form a dynamic layer of regulation. DNA methylation involves the addition of methyl groups to bases, particularly at CpG dinucleotides, typically repressing gene transcription by inhibiting the binding of transcription factors or recruiting repressive proteins; this process is maintained by enzymes like during . Histone modifications, on the other hand, entail the , methylation, phosphorylation, or other chemical alterations to proteins around which DNA is wrapped into ; for instance, histone acetylation generally loosens chromatin structure to promote gene activation, while certain methylations can either activate or repress genes depending on the specific residue modified. Additional mechanisms, such as non-coding RNAs, can also influence epigenetic states by guiding chromatin-modifying complexes to target genes. Epigenetic changes play a crucial role in normal development, , and adaptation to environmental stimuli, such as diet, stress, or toxins, which can alter the epigenome and affect outcomes across an individual's lifetime. These modifications are reversible and tissue-specific, enabling precise control over —for example, ensuring that insulin-producing genes are active only in pancreatic beta cells. Dysregulation of epigenetic processes contributes to various diseases, including cancers, where aberrant silences tumor suppressor genes, and metabolic disorders influenced by environmental exposures during critical developmental windows. Research into epigenetics holds promise for therapeutic interventions, such as drugs targeting deacetylases, and underscores the interplay between , environment, and in shaping phenotypes.

Definitions and History

Core Definition

Epigenetics was coined by British developmental biologist in to describe the branch of that studies the causal interactions between genes and their products, which bring the into being. Waddington introduced the term to bridge the gap between and , emphasizing the dynamic developmental processes that mediate how genetic information is realized in an organism's traits. In contemporary usage, epigenetics refers to stable, heritable changes in that do not involve alterations to the underlying DNA sequence. These changes encompass mechanisms such as , histone modifications, and non-coding RNA-associated , which regulate structure and accessibility to influence transcriptional activity. Unlike genetic mutations, which permanently alter the DNA sequence and are typically irreversible, epigenetic modifications are potentially reversible and can respond to environmental cues, such as diet, stress, or toxins, allowing for adaptive plasticity in gene regulation. Prominent examples include X-chromosome inactivation in female mammals, where one X chromosome is transcriptionally silenced to achieve dosage compensation, and , where parental origin determines allele-specific expression through differential epigenetic marks.

Historical Foundations

The concept of epigenesis, denoting the progressive unfolding of form during embryonic development from undifferentiated material, traces back to in the 4th century BCE, who described it as a teleological process where potentialities are realized sequentially rather than pre-existing fully formed. This view contrasted sharply with preformationism, a dominant theory from the 17th to 18th centuries, which posited that organisms develop from miniature, preformed versions of themselves encapsulated within gametes, as advocated by figures like and based on early microscopic observations of spermatozoa and eggs. The preformationist doctrine, often illustrated by homunculus models suggesting infinite regress in nested embryos, aimed to resolve debates on generation but faced challenges from observations of developmental anomalies, gradually yielding to revived epigenetic ideas by the late 18th century through naturalists like Caspar Friedrich Wolff and . In the 19th and early 20th centuries, the rediscovery of Gregor Mendel's 1865 laws of inheritance in 1900 by Hugo de Vries, Carl Correns, and Erich von Tschermak established genetics as a field focused on discrete heritable units, yet it highlighted gaps in explaining continuous phenotypic variability and environmental influences on traits beyond strict genotypic determinism. The formulation of the central dogma of molecular biology by Francis Crick in 1958, stating that genetic information flows unidirectionally from DNA to RNA to proteins, further emphasized genes as the primary drivers of heredity, but it underscored unresolved questions about how identical genotypes could yield diverse phenotypes in development and adaptation. These limitations prompted embryologists to seek mechanisms bridging genetics and environmental interactions, setting the stage for epigenetics as a complementary framework. Conrad Hal Waddington, a British developmental , formalized the term "epigenetics" in 1942 to describe the causal mechanisms operating between and during development, coining it as "the interaction of with their products in the production of ." In the , he introduced the concept of canalization, referring to the developmental buffering that stabilizes phenotypes against genetic or environmental perturbations, allowing robust pathways to form despite variability, as demonstrated in his experiments with where heat shock induced phenotypic changes that became genetically assimilated over generations. Waddington's iconic epigenetic landscape model, depicted in 1957 as a hilly terrain with branching valleys representing developmental trajectories constrained by genetic and epigenetic factors, illustrated how cells "roll" toward stable fates influenced by both internal networks and external cues, emphasizing the dynamic interplay over rigid genetic predetermination. The 1953 discovery of DNA's double-helix structure by and shifted biological focus toward , temporarily sidelining epigenetic inquiries, yet by the 1960s and 1970s, interest resurged in molecular bases for cellular memory and differentiation. A pivotal advancement came in 1975 when Robin Holliday and John Pugh, independently proposed by Arthur D. Riggs who linked it to X-chromosome inactivation, proposed that site-specific DNA modifications, particularly , serve as heritable signals maintaining gene expression states across cell divisions without altering the DNA sequence, providing a mechanism for stable in mammals. During the 1980s and 1990s, research solidified DNA methylation's role in mammals, with studies identifying its prevalence at CpG dinucleotides in genomes and its association with , as mapped in detail by Adrian Bird's group showing tissue-specific patterns that regulate imprinting and X-chromosome inactivation. Concurrently, the functional significance of acetylation emerged, building on Vincent Allfrey's 1964 detection of dynamic modifications but gaining epigenetic prominence in the 1990s through discoveries of acetyltransferases (HATs) like those identified by and David Allis, which were shown to promote open and transcriptional activation, contrasting with deacetylation's repressive effects. These findings established covalent modifications as key epigenetic regulators, integrating them into models of -mediated control.

Epigenetic Mechanisms

DNA Methylation

is a key epigenetic mechanism involving the covalent addition of a to the fifth carbon of bases in DNA, primarily at CpG dinucleotides, which represses by inhibiting binding and promoting compaction. This modification, known as (5mC), accounts for approximately 1% of total DNA bases in somatic cells. In the , there are about 28 million CpG sites, the majority of which are methylated in a tissue-specific manner to maintain cellular identity. The biochemical process is catalyzed by DNA methyltransferases (DNMTs), a family of enzymes that transfer a methyl group from S-adenosylmethionine to cytosine. DNMT1 primarily functions in maintenance methylation, recognizing hemimethylated DNA during replication to copy the parental strand's methylation pattern to the daughter strand, ensuring heritability across cell divisions. In contrast, DNMT3A and DNMT3B mediate de novo methylation, establishing new patterns on previously unmethylated DNA during development and differentiation. DNA methylation patterns exhibit dynamic alterations in disease states, such as cancer, where global hypomethylation of repetitive elements and gene bodies leads to genomic instability and activation, while hypermethylation of promoter CpG islands silences tumor suppressor genes like TP53 and BRCA1. These opposing changes contribute to tumorigenesis by disrupting normal gene regulation. Demethylation occurs through two main pathways: passive dilution, which happens during when maintenance methylation by is impaired, leading to progressive loss of 5mC over cell divisions; and active demethylation, initiated by ten-eleven translocation (TET) enzymes that oxidize 5mC to (5hmC) and further to 5-formylcytosine and 5-carboxylcytosine, which are then excised by . TET-mediated oxidation is crucial for erasing marks in processes like embryonic . This mechanism is evolutionarily conserved across prokaryotes and eukaryotes, where it serves roles in gene regulation and defense against foreign DNA, though the specific targets differ—cytosine in eukaryotes versus adenine or cytosine in bacteria. DNA methylation often interacts with histone modifications to reinforce gene silencing, such as through recruitment of proteins that deposit repressive marks like H3K9me3.

Histone Modifications

Histone modifications are post-translational alterations to the amino acid residues of histone proteins, primarily occurring on the N-terminal tails of the core histones H2A, H2B, H3, and H4, which together form the octameric nucleosome core around which DNA is wrapped to create chromatin. These modifications, including acetylation, methylation, phosphorylation, and ubiquitination, are catalyzed by specific enzymes such as histone acetyltransferases (HATs) and deacetylases (HDACs) for acetylation, and histone methyltransferases (HMTs) for methylation, thereby influencing chromatin structure and accessibility. For instance, acetylation neutralizes the positive charge on lysine residues, reducing the affinity between histones and negatively charged DNA to promote an open chromatin conformation, while methylation can either activate or repress gene expression depending on the specific residue and degree of methylation. The code hypothesis posits that combinations of these modifications on tails serve as a "code" that is recognized by effector proteins, which in turn recruit -remodeling complexes or transcriptional machinery to regulate . This hypothesis, proposed by Jenuwein and Allis, suggests that distinct modification patterns provide binding sites for reader domains, such as bromodomains that preferentially bind acetylated lysines to facilitate transcriptional . Over 100 distinct types of modifications have been identified, each contributing to the nuanced control of dynamics and genome function. Certain modifications act as activating marks, such as trimethylation of at 4 (), which is enriched at active gene promoters and correlates with ongoing transcription by recruiting factors like TFIID. In contrast, repressive marks include trimethylation of H3 at 27 (), mediated by the Polycomb repressive complex 2 (PRC2), which compacts to silence developmental genes, and trimethylation at 9 (H3K9me), associated with formation and long-term gene repression. These marks often work in opposition; for example, and can coexist at bivalent promoters in embryonic stem cells to poise genes for activation or repression during differentiation. Histone modifications are highly dynamic, with enzymes like , the catalytic subunit of PRC2, depositing in a context-specific manner during embryonic development to maintain cellular identity and prevent premature differentiation. This reversibility allows rapid responses to cellular signals, ensuring precise spatiotemporal control of . In some cases, histone modifications compound with to enhance transcriptional silencing, though their primary roles remain distinct in regulation.

Non-Coding RNAs

Non-coding RNAs (ncRNAs) constitute the vast majority of the eukaryotic transcriptome, accounting for approximately 98% of transcriptional output in humans, with the remainder encoding . These RNA molecules, which lack protein-coding capacity, exert profound influence on epigenetic by guiding chromatin-modifying complexes to specific genomic loci, thereby silencing or activating in a heritable manner without changing the underlying DNA sequence. In eukaryotes, ncRNAs have evolved as versatile regulators, conserved across species from to mammals, enabling precise control over developmental processes and genomic stability. The primary classes of ncRNAs involved in epigenetic mechanisms include microRNAs (miRNAs), small interfering RNAs (siRNAs), PIWI-interacting RNAs (piRNAs), and long non-coding RNAs (lncRNAs). miRNAs are small RNAs approximately 22 nucleotides in length that typically function post-transcriptionally by binding to target mRNAs, leading to their degradation or translational repression; however, they also contribute to epigenetic silencing by targeting the 3' untranslated regions of mRNAs encoding key epigenetic enzymes, such as DNA methyltransferases. For instance, the miR-29 family directly targets DNMT3A and DNMT3B, reducing their expression and thereby decreasing at aberrant sites. siRNAs, typically 20-25 nucleotides long, mediate (RNAi) pathways that trigger epigenetic modifications, particularly formation and , in organisms like fission yeast and plants. In these systems, siRNAs are generated from double-stranded precursors and recruit proteins to homologous genomic sequences, promoting lysine 9 (H3K9me) and subsequent . This mechanism exemplifies how siRNAs bridge RNA-based recognition with chromatin-level repression to maintain pericentromeric . piRNAs, ranging from 24 to 31 nucleotides, are specialized for protection, where they silence transposable elements (transposons) to preserve integrity during . Produced in a ping-pong amplification cycle involving clade proteins, piRNAs guide these effectors to transposon transcripts, inducing de novo DNA methylation and modifications that prevent transposon mobilization. This silencing is essential in species from flies to mammals, ensuring and transgenerational epigenetic stability. lncRNAs, defined as transcripts longer than 200 nucleotides, represent the most diverse class, often acting as scaffolds or guides for chromatin-modifying complexes to regulate large-scale epigenetic domains. In humans, the genome encodes around 20,000 lncRNA genes, many of which are primate-specific yet functionally conserved in their regulatory roles across eukaryotes. A paradigmatic example is Xist, a lncRNA expressed exclusively from the inactive X chromosome in female mammals, which coats the entire X chromosome in cis, recruiting Polycomb repressive complex 2 (PRC2) and other factors to establish silencing through H3K27 trimethylation (H3K27me3) and DNA methylation. Another well-studied lncRNA, HOTAIR, originates from the HOXC locus and interacts with PRC2 to propagate H3K27me3 marks across distant genomic regions, such as the HOXD cluster, thereby coordinating Hox gene repression during development. lncRNAs like these frequently integrate with histone modification pathways, enhancing the specificity of epigenetic control.

Other Mechanisms

Prions represent a class of epigenetic mechanisms involving heritable changes in protein conformation without alterations to the underlying DNA or RNA sequences. In yeast, the Sup35 protein can adopt a self-propagating amyloid form known as [PSI+], which induces phenotypic switches such as reduced nonsense suppression, allowing for rapid adaptation to environmental stresses through non-genetic inheritance. This prion state is maintained cytoplasmically and transmitted to daughter cells, exemplifying protein-based epigenetic memory that persists across generations. Prion-like domains in eukaryotic proteins, characterized by low-complexity sequences prone to aggregation, extend this mechanism to higher organisms; for instance, the RNA-binding protein FUS contains such a domain that facilitates phase-separated condensates but can drive pathological aggregation in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). Chromatin remodeling complexes provide another layer of epigenetic regulation by dynamically repositioning in an ATP-dependent manner, thereby influencing accessibility without covalent modifications. The family, conserved from to humans, acts as a multi-subunit motor that slides, ejects, or restructures nucleosomes to facilitate binding and enhancer activation during development and differentiation. Mutations in SWI/SNF components are prevalent in cancers and neurodevelopmental disorders, underscoring their role in maintaining epigenetic landscapes for proper cellular identity. These complexes often cooperate with variants to fine-tune nucleosome stability, bridging structural changes with functional outcomes in regulation. RNA methylation, particularly N6-methyladenosine (m6A) on , emerges as an epitranscriptomic mechanism that epigenetically modulates post-transcriptional processes. The m6A modification, installed by the METTL3-METTL14 writer complex, primarily affects mRNA stability and efficiency by recruiting reader proteins like YTHDF2, which promotes decay, or YTHDF1, which enhances cap-independent . Dysregulated m6A levels have been linked to diseases including cancer and neurological disorders, where it influences RNA localization and splicing as well. This dynamic mark integrates with other epigenetic signals to control plasticity. Nuclear architecture contributes to epigenetic inheritance through , where organizes into distinct liquid-like compartments that enforce spatial segregation of active and repressive domains. , marked by open, transcriptionally permissive structures, tends to localize centrally in the nucleus, while forms dense, peripheral condensates stabilized by interactions with lamina-associated proteins and HP1. Liquid-liquid driven by intrinsically disordered regions in proteins enables rapid reconfiguration of these compartments in response to signals, preserving epigenetic states across cell divisions. This organization not only compartmentalizes the but also influences long-range interactions essential for stable .

Molecular and Cellular Basis

Nucleosome Positioning and Histone Variants

Nucleosomes serve as the fundamental units of chromatin, consisting of approximately 147 base pairs of DNA wrapped around a histone octamer composed of two copies each of the core histones H2A, H2B, H3, and H4. This wrapping occurs in about 1.65 left-handed superhelical turns, compacting the DNA and influencing its accessibility to regulatory factors. Nucleosome positioning, which refers to the precise placement of these particles along the DNA, is not random but modulated by intrinsic DNA sequence features, such as poly(dA:dT) tracts that act as barriers to nucleosome occupancy due to their rigidity and propensity for straight conformations. These sequences promote nucleosome exclusion or repositioning, thereby creating regions of higher chromatin accessibility and facilitating processes like transcription initiation. Histone variants further diversify nucleosome function by replacing canonical histones in specific genomic contexts, altering stability and regulatory potential. For instance, the variant H2A.Z is enriched at gene promoters, where it destabilizes to enhance accessibility and promote transcriptional activation, often in combination with other marks. In contrast, the centromeric variant CENP-A substitutes for in at centromeres, forming specialized domains essential for assembly and accurate segregation during . These variants contribute to epigenetic memory by maintaining distinct states that guide cellular processes without altering the underlying DNA sequence. To prevent the inappropriate propagation of epigenetic states, domains are delineated by insulator elements, which function as barriers and boundaries. These DNA sequences, such as those bound by proteins like in vertebrates or Su(Hw) in , block the spreading of repressive or active modifications between adjacent genomic regions, thereby preserving domain-specific patterns. Insulators achieve this by facilitating higher-order looping or directly impeding the diffusion of chromatin-modifying complexes. Nucleosome positioning is inherited through semi-conservative , where parental are randomly distributed to daughter strands and complemented by newly synthesized deposited via dedicated chaperones. The assembly factor 1 (CAF-1) plays a central role in this process, preferentially depositing H3-H4 tetramers onto newly replicated DNA in a replication-coupled manner, thereby reestablishing occupancy and positioning to maintain epigenetic information across cell divisions. This mechanism ensures the propagation of positioned , particularly at regulatory elements. A subset of in active genes exhibit precise positioning, underscoring the dynamic of in transcribed regions while highlighting the importance of sequence-directed barriers for functional organization.

DNA Damage, Repair, and Epigenetic Changes

DNA damage and repair processes are intricately linked to epigenetic modifications, as the resolution of lesions often requires that can propagate or alter heritable marks such as and modifications. Double-strand breaks (DSBs) and oxidative lesions trigger signaling cascades that recruit epigenetic regulators, ensuring repair fidelity while potentially inducing long-term changes in patterns. These intersections highlight how repair pathways not only restore genomic but also influence epigenetic landscapes, with implications for cellular memory and . Oxidative damage, particularly the formation of 8-oxoguanine (8-oxoG), is primarily repaired through (BER), initiated by 8-oxoguanine DNA glycosylase 1 (OGG1). This process can alter nearby by inhibiting the methylation of adjacent cytosines in CpG dinucleotides and facilitating the recruitment of TET enzymes, which oxidize 5-methylcytosine to , promoting active demethylation via subsequent BER steps. Such changes convert signals into epigenetic responses, enabling gene activation at promoter regions without permanent sequence alterations. For instance, 8-oxoG accumulation in gene promoters acts as a transient epigenetic mark that coordinates repair with transcriptional reprogramming. In (HR), a high-fidelity DSB repair pathway, eviction and reassembly are critical for accessing damaged DNA and restoring structure. During HR, parental marked with —an active transcription-associated modification—are disassembled at break sites and preferentially reassembled onto repaired DNA, thereby propagating these epigenetic marks across generations of nucleosomes. This mechanism ensures the inheritance of active states post-repair, influencing local . HR also modifies the pattern of the repaired segment, integrating sequence restoration with epigenetic fidelity. Non-homologous end joining (NHEJ), the predominant DSB repair pathway in non-dividing cells, often results in small insertions or deletions at repair junctions, which can lead to loss of at these sites. The error-prone nature of NHEJ disrupts CpG continuity during end ligation, potentially erasing local epigenetic silencing and contributing to genomic instability or altered gene regulation. This loss at junctions provides a mechanism for epigenetic heterogeneity arising from imperfect repair. DSBs activate and signaling, which recruit epigenetic modifiers to facilitate repair. poly(ADP-ribosyl)ates histones and factors at break sites, enabling the swift recruitment of histone demethylases like KDM4D to remove repressive marks and promote relaxation for NHEJ or HR access. Similarly, kinase phosphorylates and recruits epigenetic readers such as BRD7, which in turn assembles polycomb repressive complexes to condense and suppress transcription near breaks, ensuring repair prioritization. These pathways thus couple damage sensing with dynamic epigenetic reprogramming. During , HR repair plays a pivotal role in altering genomic imprints, where double-strand breaks facilitate crossover formation that can disrupt or reconfigure patterns at imprinted loci. This process contributes to transgenerational epigenetic effects by erasing parental imprints in primordial germ cells and establishing new ones, with recombination hotspots in imprinted regions amplifying the potential for heritable changes. Such alterations ensure proper differentiation while allowing environmental influences to propagate epigenetically across generations.

Techniques for Studying Epigenetics

Chromatin immunoprecipitation (ChIP) is a foundational technique for studying protein-DNA interactions in epigenetic regulation, involving the use of antibodies to selectively pull down chromatin fragments containing specific modified histones or transcription factors bound to DNA, followed by analysis via quantitative PCR (qPCR) or high-throughput sequencing (ChIP-seq) to map binding sites genome-wide. Developed in the late 1980s and refined for sequencing applications in the 2000s, ChIP-seq enables precise identification of histone modification patterns, such as H3K27ac for active enhancers, across cell types. CUT&RUN (Cleavage Under Targets and Release Using Nuclease) is an advanced antibody-based method that uses targeted micrococcal nucase to cleave DNA near protein binding sites, offering higher resolution and reduced background compared to ChIP for mapping histone modifications and transcription factors. Introduced in 2017, it is particularly useful for low-input samples and has become a standard for precise epigenetic profiling. Bisulfite sequencing remains the gold standard for detecting DNA methylation at cytosine residues, treating genomic DNA with sodium bisulfite to convert unmethylated cytosines to uracils while leaving methylated cytosines unchanged, allowing subsequent PCR amplification and sequencing to map methylation at single-base resolution. Introduced in 1992, this method has been pivotal for quantifying 5-methylcytosine (5mC) levels in CpG islands and repetitive elements, though it requires careful optimization to minimize DNA degradation during bisulfite conversion. Methylation-sensitive restriction enzymes provide a targeted approach for differential analysis of DNA methylation by selectively digesting unmethylated DNA at recognition sites, such as HpaII (which cleaves CCGG only when unmethylated), enabling comparison of digested versus undigested fragments via PCR or Southern blotting to assess methylation status in specific loci. This enzymatic method, dating back to the 1970s but widely adopted in epigenetics by the 1990s, is cost-effective for validating methylation changes in promoter regions without full genome sequencing. Fluorescent in situ hybridization () visualizes epigenetic chromatin domains in three dimensions by hybridizing fluorescently labeled probes to specific DNA sequences in fixed cells, revealing spatial organization of modified structures like foci or topologically associating domains (TADs). Enhanced multiplexed variants, such as oligoFISH, allow simultaneous detection of multiple epigenetic marks alongside genomic loci, providing insights into nuclear architecture at the single-cell level. Nanopore sequencing offers a direct, label-free method to detect epigenetic base modifications, such as 5mC and 6mA, by measuring changes in ionic current as DNA translocates through a protein , bypassing the need for conversion and preserving long-range information. Since its application to epigenetics around , this third-generation technology has improved accuracy for native modification calling, particularly in complex genomes, with tools like Nanopolish enabling methylation detection at high accuracy (typically >85% in validated datasets). scATAC-seq (single-cell Assay for Transposase-Accessible using sequencing), developed in 2015, assays accessibility by transposase-mediated insertion of sequencing adapters into open regions, enabling epigenetic profiling of regulatory elements at individual cell resolution to uncover cell-type-specific accessibility landscapes. scATAC-seq has been integrated with multi-omics approaches (e.g., SHARE-seq in 2019) to dissect dynamic epigenetic states in heterogeneous tissues. Complementing this, long-read sequencing facilitates phasing of epigenetic marks by resolving allele-specific modifications over kilobase-scale distances, as demonstrated by tools like MethPhaser that leverage signals alongside variants. The project has extensively mapped reference epigenomes across hundreds of human cell types using these techniques, including ChIP-seq for histone marks, for , and ATAC-seq for accessibility, generating comprehensive datasets that reveal conserved epigenetic regulatory principles.

Biological Functions

Development and Cell Differentiation

Epigenetics plays a pivotal role in embryonic development by orchestrating cell fate decisions and ensuring proper tissue specification through dynamic modifications that guide the transition from totipotency to differentiated states. During early embryogenesis, the undergoes extensive epigenetic reprogramming, including waves of that erase parental imprints and activate the zygotic . This process begins shortly after fertilization, with the paternal undergoing rapid active demethylation mediated by TET3 enzymes, followed by passive demethylation in the maternal during subsequent cell divisions, facilitating zygotic activation (ZGA) around the 8-cell stage in humans. These demethylation events are essential for resetting the epigenome and enabling the expression of developmental genes, preventing the inheritance of gamete-specific marks that could disrupt lineage progression. A key example of epigenetic reprogramming is seen in the generation of induced pluripotent stem cells (iPSCs), where somatic cells are reverted to a pluripotent state using the Yamanaka factors—Oct4, , , and c-Myc. These transcription factors drive the erasure of somatic epigenetic marks, including DNA hypermethylation and repressive histone modifications, to restore an embryonic-like epigenome capable of self-renewal and differentiation. This process mimics natural developmental reprogramming but highlights the plasticity of epigenetic states, as incomplete erasure can lead to residual somatic memory that biases differentiation potential. In pluripotent cells like embryonic stem cells, bivalent chromatin domains—characterized by the coexistence of activating and repressive histone marks—poise developmental genes for timely activation during lineage commitment. These domains silence lineage-specific genes while keeping them accessible for rapid expression upon differentiation signals, ensuring coordinated cell fate transitions. As development proceeds to , DNA methylation progressively locks in differentiated states; for instance, in myoblasts, hypermethylation of non-muscle gene promoters silences alternative lineages, stabilizing myogenic identity and preventing . This epigenetic locking is crucial for maintaining tissue-specific gene expression patterns established during early embryogenesis. Environmental factors can also imprint lasting epigenetic changes during development, influencing offspring outcomes across generations. The Dutch Hunger Winter famine of 1944–1945 demonstrated this, as periconceptional exposure led to persistent hypomethylation at the IGF2 gene in adult survivors, correlating with altered growth regulation. Such influences underscore how extrinsic cues can modulate epigenetic landscapes at critical developmental windows, affecting cell differentiation and long-term physiology without altering the DNA sequence.

Gene Expression Regulation

Epigenetic mechanisms play a crucial role in fine-tuning in mature cells, enabling precise control over transcriptional activity to maintain cellular identity and respond to internal signals without altering the DNA sequence. These processes involve modifications such as histone acetylation and that alter accessibility, allowing transcription factors to bind or be repelled from regulatory regions. In steady-state conditions, these marks ensure stable yet dynamic gene regulation, distinguishing active from repressed states across the . Enhancers and silencers are key cis-regulatory elements modulated by epigenetic marks to orchestrate activity. Histone , particularly at residues like H3K27, promotes an open conformation that facilitates the formation of chromatin loops, bringing enhancers into proximity with promoters and enabling binding. For instance, by histone acetyltransferases (HATs) such as p300/CBP neutralizes positive charges on s, reducing DNA- affinity and exposing binding sites for activators. Conversely, silencers often feature repressive marks like or , which recruit Polycomb repressive complexes to compact and inhibit access, thereby silencing target . Active enhancers marked by H3K27 cover approximately 1-2% of the mammalian but are estimated to regulate up to 80% of protein-coding through long-range interactions. Feedback loops involving non-coding RNAs further refine epigenetic . MicroRNAs (miRNAs), such as miR-29, can form double-negative feedback circuits by targeting epigenetic regulators like DNA methyltransferases (DNMTs), which in turn influence at the miRNA's own genomic locus, leading to self-silencing or amplification of repressive states. This autoregulatory mechanism helps stabilize expression levels in mature cells, preventing aberrant activation. Metabolic sensing integrates cellular energy status into epigenetic control, with serving as a central metabolite that directly fuels histone . Fluctuations in levels, derived from glucose, fatty acids, or , modulate HAT activity and thus openness at regulatory elements. For example, high availability during nutrient abundance promotes of histones at active loci, enhancing transcription of metabolic , while scarcity restricts it to prioritize essential functions. Epigenetic plasticity allows environmental cues to dynamically alter marks in mature cells. Dietary components, such as like butyrate produced by , act as natural HDAC inhibitors, increasing and activating genes involved in and . This responsiveness ensures to nutritional changes while preserving cellular identity.

Transgenerational Effects

Transgenerational epigenetic inheritance refers to the transmission of epigenetic modifications across multiple generations without alterations to the underlying DNA sequence, potentially influencing phenotypes in offspring. This phenomenon challenges traditional views of inheritance by suggesting that environmental exposures can leave lasting marks on the germline, affecting descendants. In mammals, such inheritance is constrained by extensive epigenetic reprogramming during gametogenesis and early embryogenesis, yet certain marks can persist or be re-established, enabling limited transgenerational effects. During development in mammals, epigenetic reprogramming involves partial erasure of patterns, particularly in primordial germ cells (PGCs), where global demethylation occurs to reset the epigenome for totipotency. However, this process is not complete; genomic imprints—differentially methylated regions essential for parental-specific —resist erasure and are maintained through protective mechanisms involving specific DNA-binding proteins and modifications. This selective retention allows imprinted marks to be transmitted across generations, while most other epigenetic signals are wiped out, limiting the scope of transgenerational inheritance to specific loci. Mechanisms facilitating transgenerational effects include (ncRNA) transfer in and retention in oocytes. In , small RNAs such as piwi-interacting RNAs (piRNAs) and microRNAs can mediate paramutation-like silencing, where they guide or modifications in the offspring's , propagating environmental responses. For instance, exposure-induced changes in ncRNAs have been shown to integrate with , altering in subsequent generations. In oocytes, certain variants and their post-translational modifications are retained post-fertilization, escaping the paternal pronuclear demethylation wave and potentially influencing embryonic . These RNA- and -based carriers provide a molecular basis for bypassing partial barriers. Evidence from model organisms demonstrates these effects clearly. In rats, gestational exposure to the fungicide vinclozolin induces DNA hypomethylation in sperm, leading to transgenerational transmission of reduced fertility and increased disease susceptibility across at least three generations (F1 to F3), with altered methylation at over 200 loci persisting in the germline. Similarly, in Caenorhabditis elegans, 2024 studies have confirmed that small RNAs mediate heritable avoidance behaviors against pathogens, sustaining epigenetic silencing for multiple generations through ncRNA amplification in the germline. These findings highlight RNA-directed mechanisms as robust in invertebrates, contrasting with the more restricted inheritance in vertebrates, though reproducibility of such effects remains debated. In humans, transgenerational effects remain largely correlative, with historical cohort studies providing suggestive evidence. The Överkalix study in northern linked grandpaternal during periods of food scarcity, such as the 1911–1912 events, to increased metabolic disease risk in grandchildren, inherited through the paternal line. While direct causation is challenging to establish due to ethical constraints on studies, these observations align with animal models and underscore the role of early-life exposures in shaping intergenerational health outcomes via epigenetic marks.

Epigenetics in Organisms and Systems

Bacterial Epigenetics

Bacterial epigenetics refers to heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, primarily mediated through DNA methylation and nucleoid structuring in prokaryotes. Unlike eukaryotic systems, bacteria lack histones and instead rely on nucleoid-associated proteins (NAPs) such as HU and integration host factor (IHF) to compact and organize the chromosome, influencing gene accessibility and expression. HU, a highly abundant heterodimeric protein, bends and loops DNA to facilitate nucleoid compaction and regulate transcription, while IHF specifically binds to curved DNA sequences to promote architectural changes that affect promoter activity and replication initiation. These proteins enable dynamic chromatin-like organization essential for epigenetic regulation in the absence of nucleosomes. A key mechanism in bacterial epigenetics is DNA methylation, exemplified by the DNA methyltransferase (Dam) enzyme in , which specifically methylates the residue in GATC sequences shortly after replication. This methylation regulates the expression of numerous genes, including those involved in , by altering promoter activity and protein-DNA interactions; for instance, in Salmonella typhimurium, Dam methylation regulates at least 20 genes induced during , including -associated genes, enabling to host environments. In contrast to eukaryotic methylation, bacterial methylation like Dam provides rapid, sequence-specific epigenetic marks that propagate through cell divisions via hemi-methylated intermediates. Restriction-modification (RM) systems represent another cornerstone of bacterial epigenetics, functioning as primitive immune barriers that distinguish self from foreign DNA while exerting heritable epigenetic control. These systems consist of a methyltransferase that epigenetically modifies specific DNA motifs on the host and a restriction endonuclease that cleaves unmethylated DNA, such as from invading phages; the methylation pattern is inherited through semi-conservative replication, where hemi-methylated daughter strands are fully methylated before becoming susceptible to restriction. Approximately 40% of bacterial genomes harbor Type II RM systems, which not only defend against phages but also modulate by selectively permitting or blocking the integration of exogenous DNA, thereby shaping bacterial evolution and diversity. Phase variation, a epigenetic switch for reversible changes, is often mediated by methylation-dependent mechanisms in , allowing population-level bet-hedging against environmental stresses. In , flagellar phase variation between phase 1 (FliC) and phase 2 (FljB) antigens is regulated by at the hin locus, where methylation blocks recombinase access to GATC sites, stabilizing the current phase until demethylation permits switching; this heritable enhances immune evasion by generating antigenic diversity within a clonal . Such -blocked recombination exemplifies how bacterial epigenetics facilitates adaptive phenotypic heterogeneity without genetic .

Epigenetics in the Brain

Epigenetic mechanisms play a crucial role in the by modulating neural plasticity, which enables adaptive changes in neuronal structure and function in response to experience. These processes involve dynamic alterations in , modifications, and non-coding RNAs that influence without altering the underlying DNA sequence. In neural contexts, epigenetics facilitates the fine-tuning of synaptic connections and circuit remodeling, essential for learning, , and behavioral . Disruptions in these mechanisms can impair cognitive functions and contribute to neuropsychiatric conditions. During neuronal differentiation, the repressor element-1 silencing (REST) mediates repression through recruitment of Polycomb repressive complex 2 (PRC2), which deposits the mark at neuronal promoters. This epigenetic silencing prevents premature expression of neuron-specific genes in non-neuronal cells, ensuring proper timing of differentiation during development. In embryonic stem cells and neural progenitors, REST-associated complexes maintain poised states, characterized by bivalent and marks, which resolve into active or repressed configurations as cells commit to neuronal lineages. Epigenetic regulation is integral to memory formation, particularly through modulation of synaptic plasticity like (LTP) in the hippocampus. (HDAC) inhibitors, such as and , enhance LTP by increasing histone acetylation at promoters of plasticity-related genes, thereby promoting their transcription and strengthening synaptic efficacy. This effect is mediated via activation of the CREB:CBP transcriptional complex, which drives expression of genes involved in formation and . Additionally, learning experiences induce demethylation at the BDNF promoter, particularly exon IV, facilitating increased expression of (BDNF), a key regulator of synaptic growth and LTP maintenance during contextual . Stress responses in the are epigenetically shaped, with exposure altering patterns in the hippocampus to prime future reactivity. Elevated during periods of hippocampal , such as in early development, induce lasting hypermethylation at stress-responsive gene loci, shifting the transcriptional set point toward heightened sensitivity in adulthood. This programming effect persists, influencing expression and hypothalamic-pituitary-adrenal axis feedback, thereby modulating vulnerability to . Recent advances in single-cell have illuminated cell-type-specific epigenetic landscapes in the , revealing distinct DNA modification profiles between neurons and . For instance, a 2023 study using whole-genome oxidative demonstrated that neurons exhibit higher levels of hydroxymethylation (hmC) at CG sites compared to . Aberrant patterns in the , such as hypermethylation of neuronal genes, have been implicated in , contributing to dysregulated and synaptic dysfunction.

Epigenetics in Aging

Epigenetic changes accumulate with age, contributing to and reduced through mechanisms such as epigenetic drift, a characterized by the progressive loss of patterns, particularly at regions. This drift leads to global hypomethylation and site-specific hypermethylation, resulting in the erosion of structure and increased genomic instability. In aging cells, this loss of epigenetic fidelity disrupts gene regulation, promoting the expression of transposable elements and inflammation-associated genes, which exacerbate . A key tool for quantifying these age-related epigenetic alterations is the , exemplified by Horvath's 2013 model, which utilizes levels at 353 specific CpG sites across various human tissues to predict chronological age with a error of 3.6 years. This clock reveals accelerated epigenetic aging in conditions of cellular stress and correlates with attrition, where progressive shortening is associated with the erosion of the repressive mark at telomeric regions, further linking epigenetic instability to chromosomal end protection failure. Such correlations highlight how epigenetic drift intersects with dynamics to drive organismal aging phenotypes. Interventions targeting epigenetic mechanisms, such as caloric restriction, mitigate these changes by activating deacetylases like SIRT1, which enhance deacetylation and maintain integrity, thereby extending lifespan in model organisms including , worms, and mice. By increasing NAD+ levels, caloric restriction boosts activity, counteracting age-related hyperacetylation of and promoting cellular resilience against . Recent advancements in 2025 have integrated multi-omics data into epigenetic clocks, such as ensemble models combining with other layers like transcriptomics, achieving improved prediction accuracy with a median absolute error approaching ±2.5 years and higher correlations (R=0.98) to chronological age. These updates enable more precise tracking of interventions' effects on biological age, underscoring epigenetics' role in longevity research.

Medical and Clinical Applications

Genomic Imprinting and Twin Studies

represents a key epigenetic mechanism that silences specific parental , ensuring monoallelic expression of approximately 150 genes in the . These imprinted genes are crucial for growth, development, and metabolism, with the IGF2/H19 locus on chromosome 11p15.5 exemplifying parent-of-origin effects: the paternal IGF2 allele is expressed to promote fetal growth, while the maternal H19 allele produces a that represses IGF2 on the same chromosome. This differential expression arises from epigenetic marks established during , where the paternal and maternal alleles acquire distinct modifications that are stably maintained through cell divisions. The primary mechanism of genomic imprinting involves imprinting control regions (ICRs) characterized by germline-derived differentially methylated regions (DMRs). These DMRs, such as the intergenic DMR between IGF2 and H19, undergo allele-specific in (paternal marks) or oocytes (maternal marks), often involving binding sites that regulate looping and insulator function. For instance, hypomethylation of the paternal H19 DMR allows -mediated insulation, preventing IGF2 activation from the maternal , while hypermethylation on the paternal permits IGF2 expression. These gamete-specific imprints resist the global epigenetic in early embryos, ensuring parent-of-origin fidelity throughout development. Disruptions in DMR establishment or maintenance can lead to imprinting disorders, as seen in Beckwith-Wiedemann syndrome, where loss of maternal at the H19/IGF2 ICR results in biallelic IGF2 expression, causing overgrowth, , and elevated cancer risk. Twin studies, especially in monozygotic (MZ) twins who share identical genomes, highlight how environmental factors drive epigenetic variation independent of . Although MZ twins start with highly concordant epigenomes at birth, differences in accumulate over time due to divergent lifestyles, such as diet, exercise, and stress exposure. By adulthood, older MZ twins (aged 50-70 years) exhibit substantial intra-pair discordance in methylation profiles, with studies reporting differences across hundreds of CpG sites and global hypomethylation patterns reflecting environmental divergence. For example, in the Finnish Twin Cohort, BMI discordance between MZ twin pairs is associated with accelerated epigenetic aging, including altered at obesity-related loci and repetitive elements like LINE-1, where higher BMI correlates with hypomethylation and increased epigenetic age by approximately 1 month per BMI unit. These findings underscore how non-shared environments modulate epigenetic drift, providing a model for dissecting gene-environment interactions in imprinting stability and disease susceptibility.

Role in Diseases

Epigenetic dysregulation plays a central in the of various diseases by altering without changing the underlying DNA sequence. In cancer, aberrant patterns are particularly prominent, with promoter hypermethylation leading to of tumor suppressor genes and global hypomethylation contributing to genomic instability and activation. These changes are observed across multiple tumor types and represent early events in tumorigenesis. In cancers, promoter hypermethylation of the p16^INK4a gene silences this key tumor suppressor, which normally inhibits progression, thereby promoting uncontrolled proliferation; this mechanism is documented in various carcinomas, including those of the head, neck, and . Complementing this, global DNA hypomethylation affects repetitive elements and gene regions, leading to the activation of oncogenes and chromosomal instability, a phenomenon noted in the majority of human tumors as an early oncogenic driver. For instance, hypomethylation of LINE-1 retrotransposons, a marker of global demethylation, is reduced to 55-60% in tumor tissues compared to 70-90% in normal cells, correlating with aggressive disease features. Neurological disorders also exhibit profound epigenetic alterations, such as in Fragile X syndrome, where hypermethylation of the FMR1 promoter silences the gene encoding the fragile X mental retardation protein, essential for synaptic function, resulting in intellectual disability and behavioral deficits; this methylation occurs post-expansion of CGG repeats and is a hallmark of full-mutation cases. In addiction, particularly cocaine dependence, acute and chronic exposure induces histone H3 acetylation in the nucleus accumbens, a brain reward region, enhancing the expression of immediate-early genes like c-fos and reinforcing drug-seeking behavior through altered transcriptional plasticity. This cocaine-mediated increase in histone acetylation can reach approximately 50% above baseline levels following repeated administration. Metabolic diseases like type 2 diabetes involve epigenetic changes in pancreatic beta cells, where altered DNA methylation patterns impair insulin secretion and beta-cell identity maintenance. Specifically, hypermethylation or hypomethylation of genes such as PDX1 and INS disrupts glucose-stimulated insulin secretion, contributing to hyperglycemia and disease progression in susceptible individuals exposed to environmental factors like obesity. These methylation shifts are dynamic and can be influenced by aging and lifestyle, underscoring epigenetics as a bridge between environmental triggers and beta-cell dysfunction. Recent clinical data from 2025 highlight the prognostic value of epigenetics in neurodegenerative diseases, with -based epigenetic clocks derived from peripheral blood predicting progression from cognitively normal states to or , offering insights up to several years before symptom onset. Such signatures capture accelerated biological aging and correlate with and accumulation. Additionally, single nucleotide polymorphisms (SNPs) at CpG sites, including those near UBASH3B and NFKBIE loci, modulate local levels, thereby influencing disease risk by altering gene-epigenome interactions in immune and inflammatory pathways. These meSNPs (methylation quantitative trait loci) explain a significant portion of variation in and link genetic variants to phenotypic outcomes in complex diseases.

Epigenetic Therapies and Drugs

Epigenetic therapies target enzymes involved in , modification, and to reverse aberrant epigenetic alterations associated with diseases, particularly cancer. These drugs modulate without altering the underlying DNA sequence, offering potential for treating conditions where epigenetic dysregulation plays a key role. As of 2025, several classes of epigenetic inhibitors have received FDA approval, primarily for hematologic malignancies, while investigational agents continue to advance in clinical development. Histone deacetylase (HDAC) inhibitors represent one of the earliest approved classes of epigenetic drugs, functioning by blocking HDAC enzymes that remove acetyl groups from histones, leading to a more open chromatin structure and reactivation of silenced tumor suppressor genes. Vorinostat (Zolinza), approved by the FDA in 2006, is a pan-HDAC inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent, or recurrent disease on or following two systemic therapies. By inhibiting HDACs, vorinostat promotes histone acetylation, which reactivates epigenetically silenced genes and induces cell cycle arrest, differentiation, or apoptosis in cancer cells. Other HDAC inhibitors, such as romidepsin and belinostat, have also gained approval for specific lymphomas, expanding the therapeutic arsenal for epigenetic modulation in hematologic cancers. DNA methyltransferase (DNMT) inhibitors work by incorporating into DNA and covalently trapping enzymes, resulting in DNA hypomethylation that restores expression of genes silenced by hypermethylation. (Vidaza), approved by the FDA in 2004, and (Dacogen), approved in 2006, are nucleoside analogs used for the treatment of patients with myelodysplastic syndromes (MDS), including those who have failed prior or are ineligible for transplantation. These agents induce hypomethylation of DNA, leading to re-expression of tumor suppressor genes and improved hematologic responses in a significant proportion of MDS patients. Low-dose regimens of these drugs prioritize their demethylating effects over , highlighting their role as targeted epigenetic therapies. An oral formulation of combined with cedazuridine was approved in 2020 to enhance patient convenience while maintaining efficacy. Among emerging epigenetic drugs from 2020 to 2025, inhibitors of , a , have shown promise in solid tumors. Tazemetostat (Tazverik), the first EZH2 inhibitor, received accelerated FDA approval in 2020 for adults and pediatric patients aged 16 years and older with locally advanced or metastatic not eligible for complete resection. By selectively inhibiting EZH2, tazemetostat reduces marks, alleviating repression and promoting antitumor activity in EZH2-mutated or overexpressing cancers. and extraterminal motif (BET) inhibitors, which disrupt the reading of acetylated histones by BET proteins, are under investigation for inflammatory conditions and cancers. For instance, selective BET inhibitors like VYN202 are in clinical trials for , demonstrating effects by attenuating pro-inflammatory transcription. Combination therapies integrating epigenetic drugs with have emerged as a strategy to enhance antitumor immune responses in cancer trials. HDAC and DNMT inhibitors can increase presentation and reprogram the , synergizing with inhibitors like PD-1/ blockers to improve response rates in solid and hematologic malignancies. Ongoing phase III trials, such as those combining inhibitors with or , underscore this approach's potential. As of 2025, more than 20 epigenetic drugs are in phase III trials, with many emphasizing precision medicine guided by epigenomic profiling to identify responsive patients.

Research and Emerging Advances

Epigenome Editing

Epigenome editing represents a targeted approach to modify epigenetic marks on DNA and histones without altering the underlying genetic sequence, primarily leveraging catalytically inactive Cas9 (dCas9) fused to epigenetic effector domains. This technology enables precise control over by recruiting modifiers such as TET1 for to activate silenced genes or KRAB for transcriptional repression through formation. For instance, dCas9-TET1 fusions catalyze the oxidation of to at specific loci, facilitating demethylation and gene activation, while dCas9-KRAB recruits repressive complexes like TRIM28 and SETDB1 to induce marks for long-term silencing. These fusions are guided by single-guide RNAs (sgRNAs) to user-defined genomic sites, allowing multiplexed editing for complex regulatory landscapes. In therapeutic applications, epigenome editing has shown promise in silencing latent viral reservoirs and correcting hemoglobinopathies. For HIV, dCas9-KRAB fusions targeted to the HIV-1 long terminal repeat (LTR) promoter have achieved stable repression of proviral transcription in cell models by imposing repressive chromatin states, reducing viral reactivation without excising the DNA. Similarly, in sickle cell disease, dCas9 fused to activators like VP64 or p300 has been used to demethylate and acetylate enhancers at the γ-globin locus, boosting fetal hemoglobin (HbF) production to counteract sickling; recent epigenome editing of repressor binding sites in human hematopoietic stem cells restored HbF synthesis and ameliorated disease phenotypes in preclinical models. A notable 2025 preclinical study demonstrated the potential of epigenome editing for metabolic disorders, where a multiplex dCas9-p300 system reprogrammed human fibroblasts into insulin-producing β-like cells by activating key genes such as PDX1, NKX6.1, and MAFA through targeted histone acetylation. Key advantages of epigenome editing include its reversibility, as epigenetic marks can be dynamically altered or reset, and the avoidance of off-target mutations since dCas9 lacks nuclease activity, minimizing risks associated with double-strand breaks. However, challenges persist, particularly in efficient delivery of large dCas9 fusion proteins to target tissues, often requiring viral vectors or nanoparticles that face immunogenicity and transduction barriers, and in ensuring the persistence of edits against cellular turnover and incomplete epigenetic memory.00721-X) Ongoing efforts focus on optimizing effector domains and delivery systems to enhance durability in vivo.00721-X)

Advanced Methodologies

Single-cell epigenomics has advanced significantly post-2020, enabling high-resolution profiling of epigenetic states in individual cells. Single-cell bisulfite sequencing (scBS-seq) measures DNA methylation at base-pair resolution by converting unmethylated cytosines to uracils, allowing genome-wide analysis when paired with single-cell RNA sequencing. Recent tools like MethSCAn, introduced in 2024, process datasets up to 100,350 cells, incorporating read-position-aware quantitation and variably methylated regions detection to improve signal-to-noise ratios and cell-type separation, identifying over 63,000 such regions in benchmarks. Complementing this, single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) maps chromatin accessibility, with 2024 innovations like CellSpace providing scalable, sequence-informed embeddings that enhance resolution by learning joint representations of DNA k-mers and cells, mitigating batch effects across thousands of cells from multiple donors and inferring transcription factor activities without predefined motifs. Long-read sequencing technologies, such as those from PacBio and Oxford Nanopore, have revolutionized the detection of phased epigenetic modifications over kilobase-scale regions. PacBio's highly accurate long-read (HiFi) sequencing achieves over 99.9% accuracy and directly detects (5mC) modifications without chemical conversion, enabling haplotype-level phasing of patterns. Oxford Nanopore's R10.4 flowcells further improve calling accuracy with oxidative bisulfite sequencing benchmarks, reducing strand bias and supporting precise characterization across 7,000+ samples at 20x coverage. These methods surpass short-read approaches by resolving complex, repetitive genomic contexts where phasing is critical for understanding allele-specific epigenetics. Multi-omics integration combines epigenomic data with transcriptomic profiles to cell-type heterogeneity in bulk tissues. EpiDISH, an established framework updated through 2020, estimates cell-type fractions from arrays using reference-based algorithms like robust partial correlations and constrained projection, supporting for blood, epithelial, and breast tissues. When integrated with transcriptome data, it facilitates identification of cell-type-specific differentially methylated cytosines, enhancing inference in epigenome-wide association studies by virtually microdissecting mixed samples. Artificial intelligence applications, particularly , now predict epigenetic marks directly from DNA sequences with high fidelity. Recent 2025 models, such as Methyl-GP, achieve over 95% accuracy in forecasting three types of (5mC, 4mC, 6mA) across species by leveraging Gaussian processes and sequence features, outperforming convolutional neural networks in cross-validation tests. These predictive tools, built on architectures like transformers, enable annotation of uncharacterized genomes and reveal sequence determinants of epigenetic patterning without experimental assays.

Future Challenges and Directions

One major challenge in epigenetics research lies in distinguishing meaningful epigenetic signals from inherent , where variations in epigenetic marks can obscure true biological signals, complicating the interpretation of in cellular identity and processes. This issue is particularly pronounced in single-cell analyses, where technical from low-input samples further hampers accurate profiling of patterns. Additionally, off-target effects remain a critical hurdle in epigenome editing technologies, such as CRISPR-based tools, where unintended modifications to non-target sites can lead to aberrant or long-term cellular dysfunction, despite efforts to minimize them through modular designs. Validating in humans presents further difficulties, as ethical constraints limit direct experimentation, and observational studies often struggle to disentangle epigenetic effects from genetic or environmental confounders across generations. Looking ahead, personalized epigenomedicine holds promise through the integration of artificial intelligence to analyze complex epigenomic datasets, enabling tailored interventions that account for individual epigenetic profiles alongside genetic data. In environmental epigenetics, emerging directions focus on how climate change induces heritable epigenetic marks, such as altered DNA methylation in response to temperature shifts and pollution, potentially affecting population-level adaptation and disease susceptibility. A 2025 update on environmental epigenetics emphasizes the need for global initiatives to map pollution-induced changes, akin to exposome projects that track cumulative exposures and their epigenetic footprints to inform public health strategies. Integrating epigenetics with genomics, particularly by combining epigenetic risk scores with polygenic risk scores, enhances predictive accuracy for complex traits and diseases, offering a more comprehensive framework for risk stratification. Ethical concerns in epigenetics are amplified by the risks of heritable , where even transient modifications could inadvertently produce transgenerational effects, raising questions about for and equitable access to such technologies. Furthermore, the field faces misuse through pseudoscientific claims, such as unproven "epigenetic detox" regimens that falsely promise to reverse environmental damage via lifestyle interventions, diverting attention from evidence-based research and potentially harming public trust.

References

Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.